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γc   common cytokine gamma chain 
GC   germinal center 
GFP   green fluorescent protein 
HEV   high endothelial venule 
HRP   horse radish peroxidase 
IBALT   inducible bronchus-associated lymphoid tissue 
ICAM-1  intercellular adhesion molecule 1 
Id2   inhibitory of DNA binding 2 
Ig   immunoglobulin 
IL   interleukin 
ILF   isolated lymphoid folicle 
Jak   Janus kinase 
KO   knock-out 
LCMV   lymphocytic choriomeningitis virus 
LN   lymph node 
LTαβ   lymphotoxin αβ 
LTβR   lymphotoxin β Receptor 
LTi   lymphoid tissue inducer 
Lyve-1  lymphatic vessel endothelial hyaluronan receptor 1 
MAdCAM-1  mucosal addressin cell adhesion molecule 1 
MHC   major histocompatibility complex 
NALT   nasal-associated lymphoid tissue 
NF-κB  nuclear factor-kappa B 
NK   natural killer 
PBS   phosphate buffer saline 
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PCR   polymerase chain reaction 
PDGFR  platelet-derived growth factor receptor 
PNAd   peripheral node addressin 
PP   Peyer’s patch 
RA   rheumatoid arthritis 
RAG   recombination-activating genes 
RNA   ribonucleic acid 
RORγ   retinoic acid-related orphan receptor γ 
RIP   rat insulin promoter 
s.c.   sub-cutaneously 
SCF   stem cell factor 
SLC   secondary lymphoid chemokine (CCL21) 
SLO   secondary lymphoid organ 
STAT   signal transducer and activator of transcription 
TCR   T cell receptor 
tg   transgenic 
TLO   tertiary lymphoid organ 
TLR   Toll-like receptor 
TNF   tumor necrosis factor 
TRAF6  TNF receptor associated 6 
TRANCE  TNF-related activation-induced chemokine 
TRANCER  TNF-related activation-induced chemokine receptor 
VCAM-1  vascular cell adhesion molecule 1 
WT   wild type 
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SUMMARY 
During embryogenesis, the development of secondary lymphoid organs (SLOs) 
such as lymph nodes (LNs) and Peyer’s patches (PPs) requires the cellular crosstalk 
between vascular cell adhesion molecule (VCAM)-1+ mesenchymal organizer cells 
and CD45+CD4+lin- lymphoid tissue inducer (LTi) cells. The cascade of events 
leading to functional SLOs is triggered by the activation of the lymphotoxin β receptor 
(LTβR) signalling pathway. LTi cells express the corresponding ligand lymphotoxin 
(LT) αβ, and other tumor necrosis factor super-family members, chemokine 
receptors, adhesion molecules and Interleukin 7 Receptor alpha (IL-7Rα), which 
contribute to the formation of SLOs. However, the precise mechanism of surface 
receptor engagement for lympho-organogenesis and LTi cell function was not fully 
understood. In addition, it remained unclear if LTi cells could persist in adult mice, 
and had a function in the adult immune system.  
In order to better understand the role of IL-7 in SLO development, we generated a 
double transgenic mouse model overexpressing IL-7 under the control of an 
ubiquitous promoter (termed H-IL-7). These mice developed additional ectopic LNs 
and PPs (1). Ectopic SLO development was strictly dependent on LTi cells. We 
further showed that the development of ectopic SLOs was mediated by an IL-7-
driven increase in the survival of fetal LTi cells and its progenitors.  
CD4+lin- cells were found in significant numbers in all SLOs of adult H-IL-7 mice. 
This study was performed to characterize CD4+lin- cells in adult mice, and to identify 
their function. Adult CD4+lin- cells shared the phenotype with fetal LTi cells, including 
the expression of retinoic acid-related orphan receptor (ROR) γt. By transferring adult 
CD4+lin- cells into PP-deficient CXCR5-/- mice, we demonstrated their ability to 
generate lymphoid tissue. Thus, adult CD4+lin- cells were bona fide LTi cells.  
In order to test if adult LTi cells were present in normal wild type (WT) mice, and 
could respond to IL-7, we treated adult WT mice with IL-7/anti-IL-7 antibody (Ab) 
complexes. The pool of LTi cells was significantly increased in treated as compared 
to untreated mice demonstrating that adult LTi cells were responsive to IL-7. 
We further investigated the origin of adult LTi cells. We could show that the adult 
bone marrow (BM) could give rise to LTi cells, which was even more pronounced, 
7
  
when normal WT mice were treated with IL-7/anti-IL-7 Ab complex. BM cells were, 
however, far less efficient in generating LTi cells than fetal liver (FL) cells. 
It is well established that chronic inflammatory diseases in humans are often 
associated with a process termed "lymphoid neogenesis". Lymphoid neogenesis 
leads to the development of tertiary lymphoid organs (TLOs) in non-lymphoid organs. 
In several autoimmune diseases, a correlation between TLO development and IL-7 
production has been reported, but experimental evidence for a causal role of IL-7 in 
TLO development was lacking. In adult H-IL-7 mice, we observed the development of 
TLOs in several non-lymphoid organs such as the salivary gland. Moreover, these 
TLOs were either diffuse or segregated in B and T cell areas, a hallmark of normal 
SLOs. LTi cells colonized the salivary gland before naive lymphocytes, but were not 
strictly required for TLO development. In contrast, the expression of LTα was 
essential for the organization of TLOs into segregated compartments. 
To test if local inflammation could trigger the development of TLOs in H-IL-7 mice, 
we infected mice s.c. with Leishmania major. At sites of infection but not in non-
infected H-IL-7 mice, we found additional ectopic LNs. Moreover, the number of LTi 
cells was significantly increased in the draining LNs of both WT and H-IL-7 infected 
mice compared to non-infected. Altogether, these data show that the overexpression 
of IL-7 was able to induce lymphoid neogenesis at ecopic sites. 
In summary, this study shows that IL-7 is an important cytokine for the regulation 
of TLO development in adult mice. We have identified adult LTi cells, which infiltrate 
TLOs and may have a function in organizing the architecture of TLOs through 
activation of the LTβR signalling pathway. 
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1. INTRODUCTION 
1.1. Secondary lymphoid organs 
Humans are continuously exposed to various pathogens like viruses, bacteria or 
worms. The innate and adaptive immune system has evolved as a defence strategy 
against these pathogens. Adaptive immune responses are initiated in secondary 
lymphoid organs (SLOs), through the cognate recognition of antigen (Ag) by specific 
B and T cells, which are the effector cells of the adaptive immune system. SLOs 
comprise the spleen, lymph nodes (LNs), Peyer’s patches (PPs), nasal-associated 
lymphoid tissue (NALT), tonsils and appendix.  
SLOs are found in all jawed vertebrates. They are located at strategic sites of the 
body allowing a quick and effective activation of Ag-specific B and T cells. The 
development of SLOs is restricted to embryogenesis (2). 
LNs are encapsulated by a lymphatic endothelium and are connected to the 
lymphatic system. The lymph enters the LN by the afferent lymphatic vessel into the 
subcapsular sinus. From the subcapsular sinus, trabecular sinuses transport the 
lymph through the LN, until the efferent lymphatic sinus.  
LNs are composed of three compartments, the cortex, the paracortex and the 
medulla (figure 1). The cortex contains B cell follicles that mature into secondary 
follicles upon Ag stimulation. Secondary follicles contain germinal centres (GCs), 
which are the sites for clonal proliferation of B cells inducing the specific expression 
of immunoglobulins (Igs). Located in B cell follicles, follicular dendritic cells (FDCs) 
are stromal cells implicated in Ag presentation to B cells. The recruitment and 
positioning of lymphocytes and dendritic cells (DCs) in LNs are regulated by the 
localized production of homeostatic chemokines by stromal cells (3, 4). For example, 
FDCs produce CXCL13, the chemokine responsible for the recruitment of B cells and 
the formation of B cell follicles. The paracortex is composed of T cells and DCs. 
Moreover, specific postcapillary high endothelial venules (HEVs) are found in the 
paracortex. HEVs are a hallmark of LNs and PPs, allowing the entry of naive 
lymphocytes into PPs and LNs. T and B cells enter the LN by extravasation across 
HEVs, while soluble Ags and DCs enter via afferent lymphatic vessels. All cells leave 
the LN via the efferent lymphatic vessel to be delivered to enter the blood circulation. 
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The medulla contains lymph-draining sinuses, plasma cells, macrophages and 
memory T cells, but its function is not yet well undestood. 
 
Figure 1. LN architecture. LNs are surrounded by a subcapsular sinus protected by a capsule. They 
are composed of the cortex, the paracortex, and the medulla. The cortex is the site where B cell 
follicles are located. Upon Ag stimulation, primary B cell follicles mature into secondary B cell follicles 
with GC. The paracortex contains T cells, DCs and HEVs. The expression of various chemokines 
orchestrates the positioning of the lymphocytes entering the LN. Moreover, HEVs express chemokines 
that induce the recruitment of naive lymphocytes. All cells exit the LN via the efferent lymphatic vessel. 
 
PPs are the most prominent component of the gut-associated lymphoid tissue 
(GALT) in intestinal mucosa. PPs are located on the anti-mesenteric wall of the small 
intestine below the follicle-associated epithelium (FAE), containing M cells. These 
cells transport luminal Ags to lymphoid follicles (5). The number and position of PPs 
are constant, but depends on the genetic background of the mouse strain. The 
microarchitecture is composed of B cell follicles and interfollicular T cell zones 
containing T lymphocytes, DCs, macrophages and HEVs. In addition, DCs are 
localized in close contact to M cells within the FAE and in the subepithelial dome. 
PPs are the sites where primary immune responses against intestinal mucosal 
pathogens are generated. In PP-deficient mice, however, mucosal immune 
Adapted from Drayton et al. 2006. Nature Immunology 7(4): 344  
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responses are still observed. It has been shown that mesenteric LNs may serve as 
an alternative site for the induction of immune responses (6).  
In addition to PPs, the GALT comprises cryptopatches (CPs) and isolated 
lymphoid follicles (ILFs), present on the anti-mesenteric wall of the intestine. Unlike 
PPs, CPs and ILFs appear after birth. CPs are lymphoid aggregates mainly 
composed of lineage negative cells expressing c-Kit (7). ILFs are inducible lymphoid 
tissues that develop after colonization of the intestine with bacteria (8). Thus, ILFs 
may replace conventional SLOs during adaptive immune response. ILFs are 
composed of B cells, DCs, T cells and RORγt+c-Kit+IL-7Rα+ cells. Apart from cell 
composition, CPs are similar to ILFs (9, 10). Morphological studies suggest that CPs 
can differentiate into ILFs upon infection (10). 
Colonic lymphoid patches and ILFs in the large intestine are also parts of the 
GALT (11), and display an architecture similar to PPs and ILFs in the small intestine 
(11).  
Both, LN and PP development requires the cellular crosstalk between lymphotoxin 
(LT) αβ+ hematopoietic and LTβ receptor (LTβR)+ mesenchymal cells (2) (see also 
1.1.3 and 1.1.4). Similar to LN and PP development, the splenic white pulp develop 
during embryogenesis as a result of crosstalk between hematopoietic and 
mesenchymal cells. Studies in mutant mice, however, have shown that cytokines 
required for lympho-organogenesis may differ between LNs, PPs and NALT. In many 
knock-out (KO) mice, the number of peripheral LNs is reduced, whereas mesenteric 
LNs are present, indicating a site-specific regulation of peripheral versus mesenteric 
LN development. Similarly, there are some differences in the cellular regulation of LN 
and PP development. For example, additional cell subsets such as RET+CD11c+ 
cells have been shown to contribute to the formation of PP anlagen, but not of LNs 
(12).  
1.1.1. Lymphoid tissue inducer cells  
In the early 1990’s, Kelly and Scollay have identified a new population of cells 
expressing CD4 but not CD3 (13). These cells are present in the neonatal LN at a 
high proportion and they are Thy-1lowCD44+. They have a lymphoid morphology, but 
their origin and function have not been determined at that time. Some years later, 
Mebius and colleagues have shown that CD4+CD3- cells express LTαβ but, except 
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for CD4, are negative for all other lymphoid, myeloid and erythroid lineage markers. 
Moreover, these cells are amongst the earliest hematopoietic cells colonizing the 
fetal intestine as well as LN anlagen and spleen (14-16), suggesting a role in the 
development of lymphoid tissue architecture. Yoshida et al. have shown that blocking 
IL-7Rα function prevents the development of PPs. Since CD4+CD3- cells express IL-
7Rα, they have proposed that these cells are required for PP development (16). Two 
experimental approaches have demonstrated that CD4+CD3- cells are lymphoid 
tissue inducer (LTi) cells. Firstly, the adoptive transfer of the cells could restore the 
formation of PP and NALT anlagen in CXCR5-/- or Id2-/- mice, respectively (17, 18). 
Secondly, mice lacking CD4+CD3- cells have been shown to completely lack LNs and 
PPs (19, 20).  
The phenotype of IL-7Rα+CD4+CD3- cells has been carefully described (15, 16). 
IL-7Rα+CD4+CD3- cells express LTαβ, TRANCE, LIGHT, TNFα, which are ligands of 
the tumor necrosis factor (TNF) family, the chemokine receptors CXCR5 and CCR7, 
the adhesion molecules α4β1, α4β7 and ICAM-1. Moreover these cells are positive 
for CD25, CD44, CD90, CD122, CD117, CD132 (15, 21) (figure 2). Amongst IL-
7Rα+CD3- cells, both CD4+ and CD4- subsets exist that have been shown to share 
the same surface marker expression (16). Different proportions of CD4+ and CD4- 
were found in various LNs (22). Functional experiments with CD4- cells have not 
been done and it remains to be tested if they belong to the LTi cell population.  
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Figure 2. Phenotype of LTi cells (15, 21). LTi cells express CD4 and IL-7Rα, as well as TNF family 
members, chemokine receptors and adhesion molecules. Moreover, LTi cells are dependent on the 
RORγ, Id2 and Ikaros transcription factors for their differentiation. 
  
Two IL-7Rα+ LTi cell progenitor populations have been described in the fetal liver 
(FL) (23, 24). Firstly, Mebius and co-workers have characterized IL-7Rα+Sca-1lowc-
Kitlow cells in the FL (23). These FL cells were able to differentiate in vivo and in vitro 
into CD45+CD4+CD3- LTi cells, T cells, B cells, natural killer (NK) cells and DCs. In 
addition, in vitro these progenitors were able to differentiate into macrophages. 
Nishikawa and colleagues have described a lin-IL-7Rα+α4β7+ cell population that 
could differentiate into CD45+CD4+CD3- LTi cells, T cells, NK cells and DCs. No 
differentiation of these progenitors into B cells could be observed (24).  
The differentiation of progenitors into CD45+CD4+CD3- LTi cells requires the 
presence of the transcription factor Ikaros (25) and the protein Id2 (18, 20), which is a 
member of the Id family. Id proteins are inhibitors of basic helix-loop-helix 
transcription factors and play an important role in the regulation of lineage 
13
  
commitment and differentiation. In Id2-deficient mice, LTi cells are absent and LNs, 
PPs and NALT do not develop.  
Another molecule required for the generation of LTi cells is the nuclear retinoic 
acid related-orphan receptor RORγt (19). Apart from promoting survival of double 
positive thymocytes, RORγt is expressed by LTi cells, and by proinflammatory IL-17+ 
T helper cells (19, 26). In mice lacking RORγt, LTi cells are undetectable (19), LNs 
and PPs do not develop, and the thymus is abnormal (27). NALT development, 
however, is normal in these mice (28), suggesting that NALT development does not 
strictly require the presence of RORγt+ LTi cells (18).  
LTi cells co-express TNF-related activation-induced chemokine (TRANCE) and 
TRANCER (29). TRANCE-deficient mice have a lower number of LTi cells and LNs 
are absent in these mice (29-31). By overexpressing TRANCE, the number of LTi 
cells can be rescued (32). Moreover, TRANCE induces the upregulation of LTαβ on 
the surface of LTi cells (33). These data strongly suggest that TRANCE promotes the 
generation and regulates the function of LTi cells.  
Altogether, LTi cells are a unique subset of cells derived from IL-7Rα+ FL 
precursor cells, which can induce the development of SLO anlagen through 
interaction with LTβR expressed by mesenchymal cells (see also 1.1.3 and 1.1.4).    
1.1.2. LTi cells in adult mice 
In several studies, the question has been addressed if adult LTi cells exist, which 
may contribute to lymphoid tissue development/organization under normal and 
inflammatory conditions. 
The accumulation of CD45+CD4+CD3- cells has been shown more than 10 years 
ago in helminth-infected adult mice (34). Mice infected with the parasite developed 
splenomegaly and hepatomegaly. The authors have shown that splenocytes 
enriched for CD4+ cells and cultured in presence of the parasite downregulated T cell 
receptor (TCR) and CD3 and resembled large granular lymphocytes. The CD4-
enriched population contained maybe both CD4+CD3+TCR+ T cells and CD4+CD3-
TCR- LTi-like cells, the latter being selected by the parasite, the other dying. In vivo, 
flow cytometry analysis of spleen and liver of infected mice revealed an increased 
number of CD4+CD3- cells compared to uninfected mice. It has been hypothesized 
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that these cells may play a role in  maintaining the balance between host and 
parasite (34). 
In a transgenic (tg) mouse model using GFP as a reporter gene inserted into the 
Rorc(γt) gene (35), clusters of RORγt+ cells within CPs, and to a lesser extent in ILFs 
and in the subepithelial dome of PPs were observed 1-2 weeks after birth. RORγt+ 
cells expressed c-Kit and IL-7Rα, but, apart from CD4, no other lineage marker. The 
phenotype of lin-c-Kit+IL-7Rα+ cells was similar to fetal LTi cells. Adult lin-c-Kit+IL-
7Rα+ cells were therefore thought to be the adult counterpart of fetal LTi cells. In 
RORγ-deficient mice, neither intestinal lin-c-Kit+IL-7Rα+, nor CPs and ILFs were 
found (35, 36), suggesting that lin-c-Kit+IL-7Rα+ LTi-like cells in adult mice supported 
the formation of organized GALT in the intestine, including both CPs and ILFs. 
Indeed, a recent study shows that transfer of RORγt+ LTi-like cells into RORγ-
deficient mice that are devoid of CPs and ILFs, induces the development of 
organized structures in the gut (37). As transfer of wild type (WT) bone marrow (BM) 
into LTα-/- or γc-/- allows the reconstitution of CPs and ILFs, BM may be a source of 
LTi-like cell precursors (36, 37).  
In the spleen of adult mice a population of cells resembling adult LTi-like cells has 
been described. CD4+CD3- cells were located at the B/T interface in the marginal 
sinus and in B cell follicles. Histological analysis showed that at both places, 
CD4+CD3- cells were in close contact with primed T cells. CD4+CD3- cells expressed 
high levels of the T cell costimulatory molecules OX40L and CD30L, members of the 
TNF family. The receptors OX40 and CD30 were expressed by primed, but not naive 
T cells. Therefore, CD4+CD3- cells may be potential candidate for providing co-
stimulatory signals to primed T cells (21). OX40L and CD30L were exclusively 
expressed by adult but not fetal CD4+CD3- cells after in vitro culture (38). However, 
addition of IL-7 to fetal LTi cells increased CD30L expression (39). 
The adoptive transfer of WT splenocytes into LTα-/- mice was not able to restore 
splenic organization. Nevertheless, transfer of LTα-/- splenocytes into RAG-/- mice 
induces a normal organization (40), suggesting that a cell type present in RAG-/- mice 
was able to induce splenic organization in the presence of lymphocytes. Adult LTi-
like cells express high levels of LTα and LTβ mRNA (40) and are therefore a good 
candidate. Indeed, fetal and adult LTi cells, but not lymphocytes or DCs were able to 
restore B/T segregation in the spleen of LTα-deficient mice (40).  
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Taken together, these data suggest that, in addition to their function in mucosal 
immunity and T cell priming, LTi cells may be important for splenic organization. 
Blocking LTαβ with a soluble LTβR-huFc resulted in loss of discrete B cell follicles 
and altered the marginal zone (41). These findings demonstrate that continuous 
LTβR signals are required to maintain the splenic organization.  
During acute infection with lymphocytic choriomeningitis virus (LCMV), antiviral 
cytotoxic T cells destroy infected T cell zone stromal cells, leading to SLO disruption. 
The gp38+ fibroblastic reticular cell (FRC) network in the white pulp is mainly 
affected. In consequence, the host becomes unable to respond to pathogens and 
loses immunocompetence. LCMV infection was shown to be followed by the 
accumulation of CD45+CD4+IL-7Rα+lin- cells in spleen and LNs, probably due to 
proliferation of an existing pool of cells. The cell number arised the maximum at the 
peak of infection. In the absence of CD45+CD4+IL-7Rα+lin- cells, the reorganization of 
the spleen was delayed. In RORγ-/- chimeric mice, the injection of CD45+CD4+IL-
7Rα+lin- cells accelerated the restoration of the splenic architecture. These 
experiments show that LTi cells are important for SLO organization during the entire 
life. Continuous crosstalk with stromal cells is crucial for SLO maintenance as well as 
for restoration after tissue-damaging infections (42). 
1.1.3. Mesenchymal organizer cells 
By whole mount immunostainings, Adachi and colleagues have shown the 
presence of vascular cell adhesion molecule (VCAM)-1+ cells in the gut, as early as 
embryonic day (E) 15.5 (14). In primitive anlagen, VCAM-1+ cells and IL-7Rα+ LTi 
cells co-localized, suggesting that they collaborated in generating PP anlagen. 
VCAM-1+ cells have been called “organizer” cells and have been characterized in 
more details. Organizer cells express LTβR and other adhesion molecules, such as 
ICAM-1 and MAdCAM-1 (33). In addition, they co-express platelet-derived growth 
factor receptor α (PDGFRα) and PDGFRβ, suggesting a mesenchymal origin (43). 
Organizer cells also express TRANCE and produce IL-7 and the chemokines 
CXCL13, CCL19 and CCL21 (33, 44), which are potent chemoattractants for LTi cells 
(33, 43, 45). No cell surface marker specific for hematopoietic or endothelial cells 
could be detected on organizer cells. They are an active component of PP 
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organogenesis, with the capacity to recruit mature lymphocytes and organize 
lymphoid tissue compartmentalization. 
Cupedo and colleagues have found a LN equivalent to PP organizer cells, co-
expressing VCAM-1, ICAM-1 and MAdCAM-1 (33). They described two distinct types 
of organizer cells, thereby showing the diversity existing in VCAM-1+ICAM-1+ cells 
(33). The proportion of VCAM-1highICAM-1high cells was higher than VCAM-1intICAM-
1int cells in mesenteric compared to peripheral LNs, respectively (33), suggesting 
difference in the molecular requirements for mesenteric and peripheral LN 
development.  
VCAM-1highICAM-1high cells from E17.5 LNs and PPs have been shown to be 
distinct populations (46). Indeed, IL-7 expression is higher in LNs than in PPs, in 
contrast to the chemokines CXCL13, CCL19 and CCL21 which are higher in PPs 
than in LNs. However, the expression profile of these genes becomes comparable in 
LN and PP organizer cell populations of 4 day old mice.  
Altogether, these results suggest that the mesenchymal organizer cells found in 
peripheral LNs, mesenteric LNs and PPs are different with respect to expression 
levels of various cell adhesion molecules and cytokines. This may explain why the 
deletion of one of these factors mostly affects the development of only some but not 
all SLOs. 
1.1.4. Lymph node organogenesis 
During embryogenesis, LNs form from budding of primitive lymphatic veins thereby 
forming lymph sacs imbedding stromal cells. Between E12.5 and E13.5, the early 
formation of LN anlagen consists of clusters of IL-7Rα+ cells with VCAM-1+ resident 
stromal cells. Studies in KO mice have shown that molecules of the TNF super-family 
are crucial for the development of LNs. Indeed, in the absence of LTα, LTβ or LTβR, 
LN development is blocked, indicating that the engagement of LTβR is an essential 
step for LN organogenesis (Figure 3). Indeed, injection of a LTβR agonist antibody 
(Ab) into LTα-/- mice is able to restore LN development. LTi cells express high level 
of LTαβ and are therefore a good candidate as the cellular source of LTαβ. 
Stimulation of the LTβR activates two NF-κB pathways. The classical pathway leads 
to the expression of VCAM-1, ICAM-1 and MAdCAM-1 and the alternative pathway to 
the production of the chemokines CXCL12, CXCL13 (BLC), CCL19 (ELC) and 
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CCL21 (SLC) (47). CXCL13 binds to CXCR5, the corresponding chemokine receptor 
expressed by LTi cells. Signalling through CXCR5 activates the integrin α4β1 via an 
inside-out signal (17).The activated form of α4β1 will then bind to VCAM-1, thereby 
leading to a firm adhesion between LTi and organizer cells. Since mice deficient for 
CXCR5 or CXCL13 lack most LNs, it is clear that chemokine/chemokine receptor 
family members are required for LN development. 
 
 
 
 
 
 
 
 
 
 
Figure 3. Development of SLOs starts with the cluster of VCAM-1+ mesenchymal organizer and LTi 
cells. CD4+CD3- LTi cells engage LTβR expressed by organizer cells. The LTβR signalling cascade 
induces the expression of VCAM-1 and the production of chemokines. The chemokine CXCL13 binds 
the chemokine receptor CXCR5, which triggers an inside-out signal leading to the activation of the 
integrin α4β1. This integrin binds to its high affinity receptor VCAM-1 which most likely reinforces the 
interaction between both cell types (1). Firm adhesion of both cells leads to recruitment and cluster of 
more cells (2). Finally, HEVs are formed, that allow entry of lymphocytes and their 
compartmentalization into B and T cell areas (3). 
1.1.5. Peyer’s patch organogenesis 
Adachi and colleagues have described the development of PPs in three steps 
(14). First, at E15.5, VCAM-1-expressing cells cluster and form spots that co-localize 
with ICAM-1+ cells. PP formation is initiated at the proximal end of the intestine and 
proceeds towards the distal end. The second step in PP organogenesis takes place 
at E16.5-E17.0 when VCAM-1+ICAM-1+ spots are colonized by IL-7Rα+CD4+CD3- 
cells. The third and last step, which occurs postnatally, is the migration of mature T 
and B cells into these early PP anlagen. 
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Although IL-7Rα-/- and LTβR-/- mice do not develop PPs, nor have VCAM-1 spots, 
IL-7-/- mice have VCAM-1 spots but do not develop PPs. LTα-/- mice were also 
reported to lack PPs (48, 49). Injection of LTβR agonist into LTα-/- mice does not 
restore PP development, suggesting that other signalling pathways are involved. 
1.2. Tertiary lymphoid organs 
In contrast to SLO development, which is restricted to embryogenesis, tertiary 
lymphoid organs (TLOs) are inducible lymphoid structures that develop after birth. 
TLOs are lymphocytic cell accumulations arising through a process called “lymphoid 
neogenesis” in tissues affected by chronic inflammation (50). TLOs are not restricted 
to specific anatomical locations, and they can form in non-lymphoid organs. The 
neogenesis of lymphoid tissue is observed in many human chronic inflammatory 
diseases caused by autoimmune reactions or chronic allergy, microbial infections 
and chronic allograft rejections (51) (Table 1). It is currently unclear which role TLOs 
have in the pathogenesis of the chronic diseases (52, 53). On the one hand, TLO 
formation can be protective as shown in the case of lung infection with 
Mycobacterium tuberculosis (53). In this case, the infection promotes the 
development of lymphoid structure containing GCs. Given that B cell-deficient mice 
have enhanced susceptibility to M.tuberculosis, it suggests that B cells, and by 
extension TLOs, are important for the resistance against the infection. On the other 
hand, the immune response generated by TLOs can be harmful. Upon organ 
transplantation, TLO neogenesis can occur in the graft and prove the 
microenvironment for B cell differentiation, affinity maturation and production of 
autoreactive Abs involved in graft rejection (54). 
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Table 1. 
Development of TLOs in chronic autoimmune, inflammatory and infectious diseases. 
Disease Affected organ 
Chronic autoimmune diseases   
Rheumatoid arthritis Joints 
Multiple sclerosis (EAE) Central nervous system 
Sjögren's syndrome Salivary glands 
Hashimoto's thyroiditis Thyroid gland 
Grave's disease Thyroid gland 
Myasthenia gravis Thymus 
Diabetes Pancreas 
Other inflammatory diseases   
Ulcerative colitis Large intestine 
Crohn's disease (IBD) Small intestine 
Atherosclerosis Arteries 
Infectious diseases   
Influenza Lungs 
Mycobycterium tuberculosis Lungs 
Chronic Hepatitis C Liver 
Helicobacter-pylori gastritis Gastric mucosa 
Others   
Chronic GvHD Transplant 
 
1.2.1. TLOs: similarities and differences compared to SLOs 
Lymphoid neogenesis is a dynamic process during which lymphocytic infiltrates 
evolve into aggregates that eventually organize into secondary B cell follicles with 
GCs and distinct T cell areas containing DCs and HEVs. The formation of GCs in 
TLOs indicates that immune responses can occur in these tissues. In some cases, a 
complete B cell maturation is observed in ectopic GCs, with Ag-driven clonal 
expansion. In rheumatoid arthritis (RA) and Sjögren’s syndrome, the generation of 
plasma cells in TLOs are associated with GCs, which is consistent with local Ag 
presentation, but it is not clear, whether plasma cells develop in or migrate to TLOs 
(47, 48, 51). 
20
  
While TLOs share some morphological and functional properties with SLOs, the 
physiological events that induce the de novo formation of TLOs remain unknown.  
There is evidence that, similar to SLO development, stromal cells play an 
important role in TLO formation (55). In case of chronic inflammation, local fibroblasts 
may lose their tissue function and differentiate into stromal cells producing 
homeostatic chemokines. This is the case in RA, where the fibroblast-derived 
chemokines CXCL12 and CXCL13 are overexpressed in the joints (55). This 
phenomenon of ectopic expression of chemokines is observed in many other 
inflammatory diseases, such as Sjögren’s syndrome. 
Altogether, these data suggest that in case of chronic inflammatory diseases, the 
tissue-specific stroma starts to express inappropriate chemokines that induce a 
lymphoid environment in a non-lymphoid organ (55). 
1.2.2. TLO development in tg mouse models 
TLO formation has been induced in several tg models in which inflammatory 
cytokines or lymphoid chemokines were expressed under the control of a tissue-
specific promoter. For instance, LTα expressed under the control of the rat insulin 
promoter (RIP) led to inflammatory lesions in the pancreas and in the kidney (50). 
These structures were organized like SLOs and contained all cell subsets found in 
normal SLOs. Indeed, T cells, B cells, plasma cells, FDCs, as well as HEVs were 
present in RIP-LT mice. The formation of GC and the presence of isotype switched-B 
cells in these ectopic follicles suggest that these tissues were functional and 
responded to Ag. Ecopic follicles were not associated with the development of 
diabetes. Indeed, RIP-LT mice did not spontaneously develop tissue damage, unless 
infiltrating T cells were activated (50), thereby leading to tissue destruction and 
diabetes. Experiments with the expression of either LTα alone or both LTα and LTβ 
under the control of the RIP promoter show that, although LTα alone could initiate 
TLO organogenesis, simultaneous expression of both LTα and LTβ induces lymphoid 
neogenesis with larger infiltrates, a clearer separation of the B and T zones, large 
FDC networks, higher levels of CXCL13, CCL19 and CCL21 expression, and a 
strong expression of PNAd on the luminal surface of HEVs (56). CXCL13 was shown 
to upregulate LTαβ expression by B cells, which in turn engage the LTβR on stromal 
cells. This led to increased expression of CXCL13 and further promoted follicle 
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development (57). These data establish that LTαβ and homeostatic chemokine 
expression are linked via a positive feedback loop that is critical for the development 
of SLOs and TLOs (57).  
The overexpression of CCL21 or CXCL13 in non-lymphoid tissues was sufficient 
to recruit T or B cells and to promote lymphoid neogenesis (58, 59). For example, 
overexpression of CXCL13 in the pancreas of mice induced the formation of 
lymphoid tissue and the differentiation of HEVs allowing adoptively transferred 
lymphocytes to colonize the lymphoid infiltrate and segregate into B and T cell areas 
(59). Tg mice expressing CCL21 under the control of the thyroglobulin promoter 
developed ectopic organized lymphoid tissues in the thyroid gland. In this model, LT-
expressing CD4+ T cells were more important than B cells to initiate the development 
of lymphoid infiltrates and lymphatic vessels, through a process called 
lymphangiogenesis (60). Even present in high quantity, overexpression of CCL21 in 
the skin did not lead to the development of TLOs. This implies that differences exist 
in the mechanisms leading to the development of ectopic lymphoid tissues in various 
organs (58). 
Considering that lymphoid chemokines are expressed in inflamed tissues without 
organized lymphoid tissue (61, 62), it is tempting to speculate that these chemokines 
are induced by inflammation prior to the formation of segregated B and T cell areas. 
Indeed, early expression of homeostatic chemokines may be independent of LTαβ or 
TNF, as seen in influenza-infected lungs of LTα-/- mice (63). LTα-/- mice were lacking 
peripheral LNs, but upon influenza infection, developed inducible lymphoid tissues in 
the lung. These lymphoid tissues were organized in T and B cell areas and allowed 
an immune response to occur, as demonstrated by the fact that the infection was 
cleared (63).  
Altogether, studies of lymphoid neogenesis in human diseases and animal models 
show that at least two critical events seem to be required to promote TLO formation: 
firstly, inflammation and cytokine (LTαβ, TNF) expression and secondly lymphoid 
chemokine production by stromal cells. In addition, the development of HEVs may be 
required for the recruitment of lymphocytes (51).  
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1.2.3. Role of LTi cells in TLO development 
Although LTi cells are clearly required for LN and PP development, a role in TLO 
development or maintenance remains to be elucidated. In a study using RIP-BLC tg 
mice, CD4+CD3- LTi cells were the first hematopoietic cells recruited to the islets very 
early after birth (59). This suggests that LTi cells may be involved in the development 
of TLO that will eventually later develop at this place.  
The transfer of neonatal LN-derived cells or sorted LTi cells to ectopic sites, like 
the skin, of newborn mice was followed by the de novo formation of lymphoid tissue. 
However, the transfer of LTi cells to adult mice only generated disorganized clusters 
of lymphocytes without FDCs or HEVs (64). This indicates that although neonatal LN-
derived cells can induce the development of TLOs attracting mature lymphocytes, the 
environment in adult mice is inappropriate for lymphoid tissue neogenesis. This may 
be due to a lack of inflammation or a too low number of LTαβ-expressing LTi cells. B 
cells also express LTαβ, but apparently, this signalling is not sufficient to induce 
compartmentalization of B and T cell areas.  
Recent studies using mice expressing CCL21 in the thyroid gland show that the 
first cells appearing in the thyroid gland were CD4+ T cells and not LTi cells. 
Moreover, in CCL21 tg x Id2-/- mice, TLO formation was not affected (65). This study 
shows that TLO development in this mouse model does not require Id2-dependent 
LTi cells. 
To summarize all the data obtained from various animal models, the development 
of TLOs is probably coordinated by many factors including the induction of 
chemokine expression and the influx of various hematopoietic cells. 
1.2.4. TLOs and autoimmunity 
TLOs often develop in autoimmune diseases at sites of chronic immune attack. 
The main autoimmune diseases and the respective affected organs are listed in 
Table 1. 
In many cases, the formation of well-developed ectopic follicles in these sites 
correlates with increased severity of the disease and the local production of auto-
Abs. For example, RA is an autoimmune disease characterized by the chronic 
inflammation of the joints leading to progressive destruction of cartilage and bone 
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(66). Patients with RA can be divided into different groups, with either diffuse 
lymphoid aggregates in their synovium, or B and T cell aggregates, or finally highly 
developed GCs, FDCs and segregated B and T cell areas (62, 67). 
Mice expressing LCMV glycoprotein in pancreatic islets develop islet-associated 
lymphoid tissues and autoimmune diabetes upon immunization with DCs that display 
the cytotoxic T lymphocyte epitope from the LCMV glycoprotein (68). These data 
indicate that DCs also have an important role in lymphoid neogenesis (68). Indeed, 
DCs are an important source of chemokines and survival factors and may facilitate 
lymphocyte homing and compartmentalization in inflamed tissues (68). The role of 
the DCs could also be to prime T cells in spleen and LNs, which in turn would induce 
lymphoid neogenesis. 
Sjögren’s syndrome is an autoimmune disease characterized by infiltration of 
activated T cells around the duct in the salivary gland (69). Infiltrating leukocytes are 
mainly T cells, but substantial numbers of B cells and plasma cells are also present in 
inflamed tissues (70). These infiltrates can further develop into ectopic lymphoid 
tissue. The development of GCs has been reported and may contribute to disease 
progression (69). The formation of ectopic GCs in Sjögren’s syndrome patients is, at 
least in part, driven by abnormal expression of cytokines and chemokines, such as 
TNF, LT, CXCL13 and CCL21 (71).  
Autoimmune diseases are very complex and until now there are no evidences 
whether TLO development triggers the disease or is a consequence of it. From 
studies on mouse models, it seems that autoimmunity promotes the development of 
TLO in the affected organ, rather than resulting from it. As previously discussed, 
studies in tg mouse models suggest that cytokine- or chemokine-induced 
development of ectopic lymphoid tissue does not automatically lead to autoimmunity 
(59, 72). However, once established, TLO may contribute to the persistence of 
chronic stimulation and autoimmune reactions instead of clearing the disease. 
1.2.5. TLOs and infection 
The development of TLO can also occur as a response to local infections (table 1). 
For example, it is well established that the lungs are a common site for the 
formation of TLOs called “inducible bronchus-associated lymphoid tissue (iBALT)” in 
response to acute or chronic lung infections (63) or in case of pulmonary disease or 
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pulmonary fibrosis (52). Infection with Influenza virus induces iBALT formation, 
consisting of B cell follicles with GCs and FDCs, T cell areas with CD11c+ DCs, 
PNAd+ HEVs and lymphatic vessels. IBALT participates in lymphocyte priming, and 
mice lacking all conventional SLOs except iBALT survive higher doses of influenza 
than WT mice (63). This implicates that iBALT is able to promote local protective 
immunity. In iBALT, as in many TLOs, CXCL13 is expressed on reticular cells in B 
follicles, and CCL21 is expressed on PNAd+ HEVs. Upon lung infection, CXCL13 and 
CCL21 expression is induced by a LTα- and TNF-independent mechanism (63). 
However, in LTα-/- or LTβR-/- mice, iBALT is not properly organized. This may be due 
to the lack of appropriate LTα-dependent stromal cells or HEVs, which are critically 
required for lymphoid tissue organization. 
In summary, peripheral organs such as the lungs can react to viral infection by 
developing ectopic lymphoid tissue. Comparing data obtained from mouse models 
with TLO development, it is tempting to speculate that TLOs formed in response to 
viral infection are able to fight against the pathogen and to clear the infection. In 
contrast, TLOs formed in response to chronic inflammation or autoimmunity, may 
have a pathological role, worsening instead of healing the disease. 
1.3. Interleukin 7 
Human and mouse IL-7 have been cloned in the late 1980’s (73, 74) and their 
genomic sequences share 81% homology. The murine IL-7 cDNA is 462 base pair 
long and it forms a protein of 154 amino acids, which molecular weight represents 
14.9 kDa (74).  
IL-7 is expressed by mesenchymal and epithelial cells in the gut, BM and thymus. 
In addition, IL-7 can also be expressed by fibroblasts, smooth muscle cells, 
keratinocytes and DCs following activation (75, 76). IL-7 can be secreted or 
presented on the cell surface by heparin sulfate and fibronectin (75). In tissue, IL-7 is 
associated with extracellular matrix. Importantly, IL-7 expression by hematopoietic 
cells has never been observed, suggesting that only non-hematopietic cells can 
produce IL-7.  
IL-7 is a member of the IL-2/IL-15 cytokine family that signals through the common 
cytokine gamma chain (γc). In addition to γc, IL-7R is composed of IL-7Rα chain (74, 
75). 
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In mice, the expression of IL-7Rα is limited to hematopoietic cells, mostly from the 
lymphoid lineage. NK, developing T and B cells (only in mice) and mature T cells 
express IL-7Rα. Both IL-7Rα and γc subunits are expressed by LTi cells. Moreover, 
in man, IL-7Rα is also expressed by intestinal epithelial cells and BM-derived 
macrophages (75, 76).  
By binding to IL-7R, IL-7 triggers different signalling pathways, among them are 
phosphatidylinositol 3-kinase (PI3-kinase) and Src family tyrosine kinases. However, 
the most prominent one is the Janus kinase (Jak)/signal transducer and activator of 
transcription (STAT) pathway (Figure 4). Jak 1 and 3 are members of the Janus 
family of tyrosine kinases, which are important factors in cytokine receptor signalling 
pathways (76). Jak3 is constitutively associated with γc, and Jak1 is associated with 
IL-7Rα. Binding of IL-7 to IL-7Rα induces dimerization of the receptor with γc, on 
which IL-7 also possesses binding sites. Subsequently, Jak3 phosphorylates tyrosine 
residues on the cytoplasmic tail of IL-7Rα. Activated Jak1 and Jak3 then recruit and 
tyrosine-phosphorylate STAT5. This induces the dimerization and translocation of 
STAT5 to the nucleus, where transcription of IL-7 target genes occurs. TCRγ and B 
cell leukemia (Bcl) 2 are two examples of IL-7 targets (77).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. IL-7 signalling pathway. Upon binding of IL-7 on IL-7R, Jak3 phosphorylates tyrosine 
kinases on the cytoplasmic tail of IL-7Rα chain. This induces the recruitment of STAT5 and its 
phosphorylation. STAT5 dimerizes and translocates to the nucleus to start the transcription of IL-7 
target genes. 
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1.3.1. Role of IL-7 in lymphopoiesis and lymphocyte homeostasis 
IL-7 has first been defined as a hematopoietic growth factor implicated in immature 
B cell development and has been called lymphopoietin-1 (78). In mice both B and T 
cell developments are regulated by IL-7, whereas in humans, IL-7 seems to be 
required only for T cell development.  
In the thymus, IL-7 is implicated in T cell development and in γδ TCR 
rearrangement. In the periphery, IL-7 plays a role in survival/persistence of resting 
CD4 and CD8 T cells and their homeostatic turnover by increasing Bcl-2 expression. 
IL-7 may also be responsible for the differentiation of effector to memory T cells (79, 
80). Therefore, IL-7 is required for the homeostasis of peripheral T cells. 
In IL-7-deficient mice, B cell development is blocked at the pro-B cell stage, thymic 
cellularity is decreased 20-fold, αβ T cell population is reduced, whereas γδ T cells 
are nearly absent (79).  
Tg expression of IL-7 under the MHC class II promoter leads to a dramatic 
expansion of immature B cells in the BM, spleen and LNs. A 30-fold increase in 
mature T cells is observed, but thymic development is not affected (81). In T-
lymphopenic mice, the enhanced availability of IL-7 increases T cell recovery through 
reduction in apoptosis and increase in proliferation (82). These data have 
demonstrated that IL-7 has multiple effects on hematopoietic cells. 
It has been recently shown that the biological activity of IL-7 can be increased by 
combining IL-7 with an anti-IL-7 Ab (83). These findings were based on a previous 
study by the same laboratory showing that IL-2 had a poor biological activity, 
probably due to its short lifespan, and binding IL-2 with anti-IL-2 mAb before in vivo 
administration induced a strong expansion of T and NK cells (84). In order to test 
whether IL-7R+ naive and memory subsets of T cells could undergo proliferation in 
vivo, administration of IL-7/anti-IL-7 Ab complexes has been performed (83). 
Treatment of the mice with IL-7/anti-IL7 Ab complexes induced a strong expansion of 
naive and memory T cells. Moreover, IL-7/anti-IL-7 Ab complexes could restore T cell 
development in IL-7-/- mice (83). IL-7/anti-IL-7 Ab complexes displayed 50 to 100-fold 
higher efficiency than IL-7 alone. Importantly, anti-IL-7 Ab had to be pre-bound to IL-
7 to enhance the activity of the cytokine (83). The mechanism underlining the 
enhanced activity of IL-7 is likely its prolonged lifespan in vivo. 
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1.3.2. Role of IL-7 in lympho-organogenesis 
Mice lacking IL-7, IL-7Rα or signalling component of IL-7R, such as Jak3 have 
severe defects in LN and PP organogenesis (45, 85-87) thus demonstrating that IL-7 
is important during lymphoid organogenesis. Indeed, IL-7 produced by fetal organizer 
cells has a key function in inducing LTαβ expression by LTi cells (1, 44, 45).  
Yoshida and colleagues have shown that the expression of LTαβ on IL-7Rα+ LTi 
cells could be induced by both IL-7 and TRANCE (44). These data show that there is 
a partial overlap between IL-7 and TRANCE effects. TRANCER-/- and TRAF6-/- mice 
did not develop LNs, but PP development was normal. This suggests that TRAF6 is 
downstream of TRANCER, but not of LTβR, which is required for both LN and PP 
development. IL-7Rα+ cells isolated from TRAF6-/- mice did not respond to TRANCE, 
but upregulated LTαβ expression in response to IL-7 (44). Administration of IL-7 to 
TRAF6-/- embryos, which lack the TRANCE signalling pathway, was sufficient to 
trigger LN genesis. Therefore, IL-7 is able to replace TRANCER signalling for LN 
induction, but the maturation into segregated compartments is not completed and 
requires TRANCER/TRAF6 signalling.  
The role of IL-7 for LTi progenitor and LTi cell survival/proliferation remained 
unsolved until now, and was the subject of manuscript 1.  
1.3.3. Role of IL-7 in autoimmune diseases 
A role of IL-7 for disease progression was discussed in RA (88) and in other 
autoimmune diseases such as colitis (89, 90), multiple sclerosis (91) and diabetes 
(92). 
In RA patients, elevated levels of IL-7 were found in the synovial fluid, produced by 
fibroblasts, macrophages, endothelial cells and DCs (88). As already mentioned in 
the section 1.2.4, patients suffering from RA developed TLOs in their inflamed joints. 
The activation of the IL-7R signalling pathway could therefore be related to the 
development of TLOs in RA patients, and further contribute to the progression of the 
disease (67).   
Multiple sclerosis is the most common neurologic disease. It is an inflammatory 
autoimmune disease in which lymphocytes and macrophages infiltrate the central 
nervous system. Mouse models for experimental autoimmune encephalitis (EAE) 
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were used to understand the mechanisms occurring in multiple sclerosis. Among 
many other genes, an allelic variant of IL-7Rα was overexpressed in peripheral blood 
cells of patients suffering from multiple sclerosis (93).  
In all these autoimmune diseases, the elevated level of systemic IL-7 could sustain 
autoreactive T cell responses, and permit the establishment of a specific 
microenvironment for chronic autoimmune diseases. 
1.4. IL-7 overexpressing mouse models 
The first IL-7 tg mouse has been generated in 1991 by Samaridis et al (94). They 
established a tg mouse model expressing IL-7 only in lymphoid cell compartments 
such as BM, spleen and thymus. For that, IL-7 cDNA was under the control of an Ig 
kappa light chain promoter and a heavy chain enhancer. This resulted in expression 
of IL-7 transgene by circulating B and T cells. IL-7 overexpression in these mice 
induced an increase in B cell precursor number in the BM, mature B cells in the 
spleen, as well as a thymocyte and peripheral T cell expansion (94). 
In 1993, Rich and colleagues generated a tg mouse, where IL-7 cDNA was 
expressed under the control of an Ig heavy chain promoter and enhancer (95). They 
found expression of the transgene in the BM, LNs, spleen, thymus and skin. In 
addition to the previously reported lymphoproliferative disorder induced by IL-7 
overexpression, they also observed a progressive cutaneous disorder with dermal 
lymphoid infiltrate (95). 
A mouse with IL-7 expressed under the Srα promoter has been shown to develop 
chronic colitis (96). Immunohistological analysis revealed the presence of lymphoid 
infiltrates in the colonic lamina propria, mostly composed of CD4+ T cells. The 
authors suggested that chronic inflammation in the colonic mucosa was mediated by 
a colonic epithelial cell-derived IL-7 (96). 
In 1995, another IL-7 tg mouse was created, with the murine IL-7 expressed under 
the control of the MHC class II promoter (81). These mice allowed the analysis of the 
effects of IL-7 on the differentiation of fetal thymocytes, and on the development of 
the T cell repertoire. In these tg mice, IL-7 was produced by all MHC class II-
expressing cells, including the thymic epithelium. IL-7 overexpression by MHC class 
II cells induced an accumulation of T cells and immature B cells in LNs. Due to the 
presence of more immature B cells in IL-7 tg compared to WT mice, LN and spleen 
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architecture were abnormal in IL-7 tg mice. In contrast, the thymus was not altered. 
Indeed, no difference was observed between WT and IL-7 tg thymus structure, nor in 
thymocyte development (81).  
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2. AIM OF THE STUDY 
Our laboratory is investigating the role of hematopoietic cells in inducing lymphoid 
tissue formation, and the regulation of LTi cells and lymphoid tissue formation by 
cytokines such as IL-7 and thymic stromal lymphopoietin (TSLP). As main tools, 
various tg or KO mouse models are used.  
 
During my PhD, two main questions were addressed.  
 
Question 1: 
Are CD4+lin- cells in adult mice bona fide LTi cells and how are they regulated? 
 
Question 2: 
What are the roles of IL-7 and adult CD4+lin- cells in ectopic lymphoid tissue 
formation under normal or inflammatory conditions? 
 
In order to address these questions, we have created a mouse model with a 
systemic expression of IL-7. Mice expressing murine IL-7 under the control of the 
MHC class II promoter (81), called IE-IL-7, have been crossed to mice expressing the 
MHC class II transactivator (CIITA) under the control of the ubiquitous Srα promoter 
(97). In these double tg mice (termed H-IL-7), the ubiquitous synthesis of CIITA 
promotes the systemic expression of IL-7. Three to seven-folds more IL-7 transcripts 
are produced in H-IL-7 compared to IE-IL-7 mice. Alternatively to studying H-IL-7 
mice, we treated WT or IL-7-/- mice with IL-7/anti-IL-7 Ab complexes. 
 
 
Figure 5. H-IL-7 mouse model. An 
heterozygous mouse expressing 
CIITA under the control of the Srα 
promoter has been crossed with an 
heterozygous mouse expressing 
murine IL-7 under the control of the 
MHC class II (I-E) promoter. 
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Interleukin 7-induced lymphoid neogenesis 
in arthritis: recapitulation of a foetal
developmental programme?
Daniela Finke, Sandrine Schmutz
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Chronic inflammatory diseases such as
rheumatoid arthritis (RA) are associated with the
de novo formation of organised lymphoid tissue in
a subpopulation of patients. The aberrant expres-
sion of cytokines and chemokines by stromal cells
plays an important role in recruitment and sur-
vival of effector cells of the immune system and
the development of ectopic tertiary lymphoid or-
gans (TLOs). TLOs may promote the persistence
of inflammation and the recognition of self anti-
gens. Recent studies in man and mice now indi-
cate that interleukin 7 (IL-7) is implicated in the
formation of TLOs and progression of chronic
inflammation.
Key words: Interleukin 7; arthritis; inflamma-
tion; lymphoid tissue inducer cell; tertiary lymphoid
organ
Summary
IL-7 is a cytokine that uses the common
gamma chain (gc) and the IL-7 receptor a (IL-
7Ra) chain for signalling. It is primarily expressed
by epithelial and stromal cells of various organs
such as the thymus, bone marrow, intestine and
skin [1]. IL-7 is required for T lymphocyte devel-
opment and homeostasis in man and mice but
only in mice it has an additional function in B cell
development (figure 1). Apart from its role in dif-
ferentiation and survival of lymphocytes, studies
in knockout mouse models have identified IL-7 as
a critical cytokine regulating secondary lymphoid
organ (SLO) development. A specialized subset of
IL-7R-expressing haematopoietic cells named
“lymphoid tissue inducer” (LTi) cells has been
identified as a key player in generating lymph
nodes (LNs) and Peyer’s patches (PPs) [2–5]. LTi
cells form cellular aggregates with local stromal
cells and interact via adhesion and TNF family
member molecules. During this haematopoi-
etic/mesenchymal crosstalk, the production of cy-
tokines, chemokines and adhesion molecules
leads to the recruitment of leukocytes and the or-
ganisation into lymphoid compartments. 
It is well established that the development of
SLOs is completed after birth. Chronic inflam-
mation, however, is commonly associated with the
de novo formation of ectopic lymphoid organs
Introduction
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APRIL a proliferation induced ligand
Blys B lymphocyte stimulator
DC dendritic cell
GC germinal center
IFNg interferon g
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IL-7R interleukin 7 receptor
JAK3 janus-activating kinase 3
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LTab lymphotoxin ab
LTbR lymphotoxin b receptor
LTi lymphoid tissue inducer
MIP 1b macrophage inflammatory protein b
NOD non-obese diabetic
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named “tertiary lymphoid organs” (TLO). The
molecular mechanisms underlying the transfor-
mation of inflammatory infiltrates into TLOs are
not completely understood, but studies in mice
indicate that lymphoid organ development during
ontogeny and inflammation shares some common
features (figure 2). In both chronic inflammation
and organogenesis, the activation of stromal cells
leads to the release of molecules that regulate the
recruitment, proliferation and survival of leuko-
cytes. The establishment of a niche for incoming
leukocytes is mediated by the collaboration of ex-
tracellular matrix components, adhesion mole-
cules, cytokines and chemokines. Tumour necro-
sis factor (TNF) and lymphotoxin ab (LTab) ex-
pressed by haematopoietic cells are critical cy-
tokines acting on mesenchymal stromal cells and
vascular endothelial cells and promote the estab-
lishment of lymphoid niches. Despite the success
of anti-inflammatory treatment in RA, TLOs still
persist. In this review we will highlight the role of
IL-7 in SLO and TLO development and discuss
its function in the progression of RA.
Figure 1
IL-7 has multiple ef-
fects on haematopoi-
etic cells through in-
duction of cytokines,
survival and develop-
mental signals. IL-7 is
critical for the devel-
opment of human 
T cells and for the
homeostatic turnover
of naïve and memory
T cells. It also plays 
a role in dendritic cell
(DC) development,
maturation and func-
tion. Moreover, it is
important in bone
metabolism, during
lymphoorganogene-
sis and can have an
influence on autore-
active T cells leading
to autoimmune dis-
eases.
Figure 2 
SLO and TLO devel-
opment share
 common features.
Chemokines, IL-7 
and growth factors
are provided by 
mesenchymal stro-
mal cells (spindle
formed).
Haematopoietic cells
(LTi cells, T cells, B
cells, macrophages)
produce cytokines
and integrins, which
promote stromal cell
differentiation.
Development and remodelling of secondary lymphoid organs
SLO development in mice is orchestrated by
LTab+ LTi cells, which express CD4, c-Kit
(CD117) and IL-7Ra (CD127), originate from
the foetal liver and circulate during early foetal
life before they enter peripheral tissues [6]. At
sites of LN and PP anlagen, LTi cells interact with
local lymphotoxin b receptor (LTbR)+ mesenchy-
mal organizer cells thereby inducing the expres-
sion of lymphoid chemokines such as CCL19,
CXCL13 and CCL21 by the organizer cells and
the colonisation with mature leukocytes [6]. In the
absence of LTi cells or if components of the LTbR
signaling pathway are blocked, LNs and PPs do
not develop. Similarly, the formation of LNs and
PPs is impaired in mice lacking lymphoid
chemokines and chemokine receptors. This led to
the current concept of a haematopoietic/mes-
enchymal crosstalk required for the formation and
organisation of lymphoid tissue. Once SLO devel-
opment has progressed to a stage where func-
tional lymphoid compartments are established,
signals via TNF family member molecules and
chemokines help maintain a T cell/B cell segrega-
tion and germinal center (GC) reaction during
immune responses [7]. 
Mice lacking IL-7, IL-7Ra or Janus-activat-
ing kinase (JAK) 3, a signaling component of the
IL-7R, have severe defects in LN and PP develop-
ment suggesting a critical role of IL-7 in lympho-
organogenesis [8–10]. The precise nature of the
signals provided by IL-7 was unsolved until now.
We have recently shown that IL-7 induced the ex-
pression of LTab on LTi cells and amplified LTi
cell numbers through inhibiting apoptosis [11]. In
mice overexpressing IL-7 ubiquitously, lymphoid
organs were hyperplastic and additional PPs and
LNs were found. Ectopic LNs were connected to
the lymphatic system and most probably devel-
oped from budding lymph sacs. The ectopic LNs
were fully functional and supported normal T cell
dependent B cell responses and GC reactions. Al-
together, these data show that IL-7 is operative in
the development of normal and ectopic lymphoid
organs through increasing LTi cell number.
The development of SLOs during human on-
togeny is a largely unexplored field and cells with
LTi function have not been identified yet. In pa-
tients with JAK3-deficiency, RAG deficiency or
X-linked agammaglobulinaemia, LNs are hy-
poplastic and formation of GCs does not occur
[12] indicating that mature lymphocytes con-
tribute to SLO organisation. 
It is generally accepted that the developmen-
tal programme for SLO formation is completed
after birth. In patients with chronic post-inflam-
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matory and post-traumatic lymph stasis, however,
the neogenesis of LNs from intralymphatic ag-
gregates has been reported [13]. Inflammation
and immune responses in LNs lead to fibroblast
reticular cell hyperplasia followed by contraction
after resolution of the immune activation. It is a
matter of current research if the process of stroma
hyperplasia and contraction during infection is
triggered by molecular mechanisms that are also
operative during the development of SLOs. Inter-
estingly, a subset of adult CD4+CD3- cells resem-
bling foetal LTi cells was found to accumulate in
reactive LNs of Helminth infected mice [14] and
in the spleen of lymphocytic choriomeningitis
virus-infected mice [15]. Adult CD4+CD3- cells
share some phenotypic marker with foetal LTi
cells and appear to play a role in splenic organisa-
tion and immune responses [16]. Therefore, it is
possible that LTi cells have a broader function as
previously thought and act as inducers of lym-
phoid tissue during foetal and adult life.
Tertiary lymphoid organs in rheumatoid arthritis: role of IL-7
Chronic inflammatory diseases such as au-
toimmune diseases, chronic infections and
chronic graft rejection are commonly associated
with the formation of TLOs. These tissues resem-
ble SLOs with segregation into T and B cell
zones, dendritic cells (DCs), GCs, follicular den-
dritic cells, lymphatic vessels and high endothelial
venules. Transgenic mice overexpressing lym-
phoid chemokines (CXCL13, CCL19, CCL21) or
TNF family member molecules (LTab) under the
control of a tissue-specific promoter, develop site-
specific TLOs (for review see [17]). These data
suggest that TLO development during chronic
inflammation recapitulates a molecular pro-
gramme used during foetal lymphoid organ devel-
opment. The anatomical similarities between
SLOs and TLOs have led to the hypothesis that
TLOs provide the environment for generating
chronic adaptive immune responses that con-
tribute to disease progression. This concept was
confirmed by investigating chronic organ trans-
plant rejection in mouse and man where TLO for-
mation promoted B and T cell mediated allograft
rejection [18, 19]. 
RA is an autoimmune disease characterised by
chronic inflammation of the joints leading to pro-
gressive destruction of cartilage and bone [20]. B
cells, T cells, macrophages, synovial cells and en-
dothelial cells producing proinflammatory cy-
tokines are considered to be involved in the
pathogenesis of RA. In contrast to the transient
recruitment of leukocytes during the early phase
of inflammation, in many but not all patients with
established RA, fibroblast activation and hyperpla-
sia lead to the establishment of TLOs in synovial
lesions [21]. Fifty percent of patients form T/B
cell aggregates, and half of them have synovial tis-
sues containing B cell follicles with GCs [22, 23].
B cells isolated from these ectopic GCs undergo
antigen-driven clonal expansion and somatic hy-
permutation [24] leading to memory B cells and
autoantibody-producing plasma cells. The in-
creased levels of B cell survival factors such as B
lymphocyte stimulator (BLyS) and APRIL found
in RA patients may further enhance these B cell
responses [25]. Some T cells found in inflamed
joints of RA patients have a diverse autoreactive T
cell receptor repertoire [26]. Collectively, GCs in
the synovia of RA patients may collect self-anti-
gens, which can be presented to the adaptive im-
mune system and stimulate autoreactive T and B
cell responses. 
There is evidence that the development of
TLO in the synovia of RA patients is, analogous
to SLO development, coordinated by the interac-
tion of incoming LTab+ haematopoietic cells with
stromal cells (fibroblasts, endothelial cells). The
activation of the LTbR signaling pathway in syn-
ovial fibroblasts and endothelial cells may lead to
the inappropriate secretion of chemokines,
growth and survival factors for leukocytes and the
establishment of lymphoid structures. This con-
cept is further supported by the fact that synovial
tissues of RA patients overexpress LTa, LTb,
CXCL12, CXCL13, CCL21, and VCAM-1 [22,
23]. These molecules are also essential for the de-
velopment of SLOs. Recent studies in a chronic
arthritis mouse model reveal that in the absence of
corresponding chemokine receptors (CXCR5,
CCR7), TLOs fail to form followed by a signifi-
Figure 3 
A. Receptor activator of nuclear factor kB ligand (RANKL, also named TRANCE) binds
to its receptor RANK (also named TRANCER), a member of the TNF receptor super -
family.
B. IL-7-driven production of RANKL by T cells increases the pool of osteoclasts either
indirectly by differentiation of osteoclast progenitors or directly by osteoclast prolifer-
ation. (DC: dendritic cell, M: macrophage, T: T lymphocyte, OCP: osteoclast progenitor,
OC: osteoclast, TNFa: tumour necrosis factor a, M-CSF: macrophage colony stimulat-
ing factor). 
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cantly reduced joint destruction [27]. This
strongly suggests that TLO development can
contribute to the progression of the disease.
In RA patients, synovial fluid levels of IL-7
are strongly elevated [28, 29]. Fibroblasts,
macrophages, endothelial cells and DCs in the
synovia of RA patients produce IL-7 [30] (figure
3B). Interestingly, gene expression of RA synovia
reveals that increased levels of IL-7, IL-7R and
IL-7R signalling molecules are associated with
the presence of TLOs [23]. The activation of the
IL-7R signalling pathway may therefore play a
role in TLO development analogous to its role in
SLO development. Our studies in mice in which
IL-7 overexpression induces the development of
additional normal and ectopic lymphoid organs
strongly support this paradigm of an IL-7-
dependent mechanism of TLO formation [11]. 
Apart from a role in lymphoid tissue develop-
ment, IL-7 is operative in bone loss through in-
creased osteoclastogenesis mediated by T cells
producing TNFa and the receptor activator of
nuclear factor kB ligand (RANKL) [31, 32]. Both
generalised and focal bone loss is found in pa-
tients with RA [33]. Higher levels of RANKL are
detectable in synovial tissue of RA patients with
active synovitis [34]. Activated T cells and RA
stromal cells produce RANKL, which induces ac-
tivation of RANK-expressing osteoclast progeni-
tor cells and mature osteoclasts [35] (figure 3).
Thus, studies in RA patients and animal models
for arthritis highlight a role of IL-7 in secreting
osteoclastogenic molecules. In line with this, in
our IL-7 overexpressing mouse model, we ob-
served a progressive osteolysis and bone remodel-
ling irrespective of the gender (figure 4). Macro-
scopically we did not find signs of joint inflamma-
tion indicating that IL-7 alone is not sufficient 
to trigger the development of arthritis. It remains
to be investigated whether IL-7 overexpressing
mice are more susceptible to the development of
experimentally induced arthritis. Altogether, IL-7
may have a dual function in the pathogenesis of
RA through inducing TLO development and dis-
turbing the bone metabolism. In addition, the
local release of IL-7 in RA lesions might be the
driving force for leukocyte survival and differenti-
ation into potentially harmful effector cells. This
is supported by the findings that synoviocytes
from patients with RA stimulate the proliferation
of Th1 cells through IL-7 [29, 36] and that IL-7-
primed arthritogenic Th1 cells produce IFNg and
TNFa [28]. IL-7 also promotes cytotoxic T cell
and Th2 responses [37]. Moreover, IL-7 can in-
duce the secretion of IL-1a, IL-1b, IL-6, IL-8,
macrophage inflammatory protein (MIP)-1b and
TNFa by human monocytes [38–40]. The over-
expression of TNFa in animals leads to the for-
mation of TLO and the development of chronic
arthritis, which may explain only one of the mul-
tiple mechanisms of TNF in the pathogenesis of
the disease [41]. In turn, TNFa promotes the
production of IL-7 by RA fibroblasts [36]. De-
spite considerable success in treatment of RA with
anti-TNFa, a substantial proportion of patients
do not respond and IL-7 persists upon anti-
TNFa treatment [42] . In patients with RA re-
fractory to anti-TNFa agents, the selective 
depletion of CD20-positive B cells with anti-
CD20 antibodies (Rituximab) significantly re-
duces the activity of the disease in the majority of
the patients [43–45]. Rituximab-treatment is
more effective than switching to an alternative
anti-TNF agent [46] suggesting that B cells have
additional pathogenic functions in RA. The
mechanisms, by which B cell depletion leads to 
a clinical improvement of RA, may rely on the ef-
fector function of B cells in antigen-presentation
to T cells, the secretion of cytokines and the for-
mation of TLO. This is supported by the finding
that in rheumatoid synovium, LTb-producing B
cells are critical for T cell activation, production
of IFNg and IL-1b and formation of ectopic GCs
[22, 47]. IL-7 can induce the expression of LTb,
which is critical for the development of ectopic
GCs [11]. Finally, the induction of IL-7 by a
TNF-independent mechanism can further con-
tribute to establish T cell responses in TLOs.
Therapeutic blockade of local IL-7 release or
neutralisation of IL-7 protein may therefore have
beneficial effects in established RA, but systemic
immunosuppressive  effects should also be taken
into consideration. Altogether, TLO develop-
ment in inflammatory RA shares some striking
features with SLO development in mouse models.
It is initiated by infiltrating haematopoietic cells,
which activate local stromal cells. As a conse-
quence of LTb-dependent signals provided by
haematopoietic cells, the stroma produces factors,
which in turn help to establish and maintain in-
flammatory infiltrates. The local release of IL-7
may promote the chronic stimulation and survival
of immune cells and the establishment of TLO
that accounts for the progressive destruction of
the tissue. 
Figure 4
Femur of wild type
(left) and IL-7 trans-
genic (right) mouse.
IL-7 overexpression
leads to osteolysis,
lacuna formation and
contraction in length.
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A role of IL-7/IL-7R in disease progression
has also been proposed for other autoimmune
diseases in humans or mouse models such as coli-
tis [48], multiple sclerosis [49], diabetes [50], pso-
riasis [51] and sialitis in NOD mice [52]. In-
creased levels of systemic IL-7 where reported to
directly sustain autoreactive T cell responses. Ev-
idence for this comes from studies in mice where
systemic IL-7 was essential for persistence of coli-
tis [53]. The local release of IL-7 in chronically
inflamed organs, however, may help establishing
TLOs as previously discussed. In Sjögren’s syn-
drome, the dysregulated expression of lymphoid
chemokines together with the formation of TLOs
has been observed [54, 55]. It is likely that conver-
sion of fibroblasts into lymphoid stroma in the
salivary gland is supportive of the high-affinity
autoantibody production and the high incidence
of B cell lymphomas associated with Sjögren’s
syndrome. Whether human LTi cells exist and
contribute to TLO development in autoimmune
diseases is still an open question but advances in
engineering new models to study human
haematopoietic progenitor cells may provide
some tantalising clues. Altogether, autoimmunity
is a multistep process requiring proinflammatory
cytokines, growth factors, release of self-antigen
and a micromilieu supporting the expansion and
survival of self-reactive lymphocytes. Cytokines
such as IL-7 may not only play an essential role in
sustained T cell responses but also in establishing
the microenvironment for chronic autoimmune
responses.
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Development of Peyer’s patches and lymph
nodes requires the interaction between CD4+
CD3 IL-7Ra+ lymphoid-tissue inducer (LTi)
and VCAM-1+ organizer cells. Here we showed
that by promoting their survival, enhanced
expression of interleukin-7 (IL-7) in transgenic
mice resulted in accumulation of LTi cells.
With increased IL-7 availability, de novo for-
mation of VCAM-1+ Peyer’s patch anlagen oc-
curred along the entire fetal gut resulting in a
5-fold increase in Peyer’s patch numbers. IL-7
overexpression also led to formation of multiple
organized ectopic lymph nodes and cecal
patches. After immunization, ectopic lymph
nodes developed normal T cell-dependent B cell
responses and germinal centers. Mice overex-
pressing IL-7 but lacking either RORg, a factor
required for LTi cell generation, or lymphotoxin
a1b2 had neither Peyer’s patches nor ectopic
lymph nodes. Therefore, by controlling LTi cell
numbers, IL-7 can regulate the formation of
both normal and ectopic lymphoid organs.
INTRODUCTION
Peyer’s patch (PP) and lymph node (LN) organogenesis is
initiated through signaling events that require the interac-
tion between two cellular partners of hematopoietic and
mesenchymal origin (Adachi et al., 1997; Mebius et al.,
1997; Yoshida et al., 1999). Adoptive transfer studies in
mice have identified fetal hematopoietic CD45+ CD4+
CD3 cells expressing both IL-7Ra (CD127) and lympho-
toxin (LT) a1b2 as playing a pivotal role in lymphoid tissue
induction (Finke et al., 2002; Fukuyama et al., 2002). PP
development is initiated through the interaction of CD4+
CD3 lymphoid tissue inducer (LTi) cells with VCAM-1-
expressing mesenchymal cells. This cellular interaction,40which involves integrins, lymphotoxin b receptor (LTbR),
and tumor necrosis factor (TNF) receptor I (De Togni
et al., 1994; Futterer et al., 1998; Kuprash et al., 2005),
leads to cell-cluster formation, induction of chemokine
production by mesenchymal cells, and subsequent re-
cruitment of mature lymphocytes (Honda et al., 2001;
Ngo et al., 1999). Consistent with this, the chemokine
CXCL13 and its receptor have been identified as impor-
tant factors in the development of PP and LN (Ansel
et al., 2000; Forster et al., 1996).
A similar role for CD4+ CD3 cells as inducers of periph-
eral LN development was shown (Eberl et al., 2004; Yosh-
ida et al., 2002). LN development starts with the accumu-
lation of IL-7Ra+ cells at prospective sites of LN formation
in E12.5 fetal mice (Yoshida et al., 2002). Through inhibi-
tion of the LTbR pathway, it could be shown that there is
a time window (E11.5 to E16.5) for temporally and spatially
coordinated LN development (Rennert et al., 1996).
The IL-7R-signaling pathway is required for the assem-
bly of LTi and organizer cells during PP anlagen formation
(Adachi et al., 1998). Accordingly, the single injection of
a blocking IL-7R antibody (Ab) before E15.5 is sufficient
to prevent PP but not LN development (Yoshida et al.,
1999). Notably, several LN are still detectable in both
IL-7Ra-deficient mice and mice lacking the IL-7R down-
stream signaling molecule JAK3, although PP are absent
(Adachi et al., 1998; Luther et al., 2003). Altogether, these
data imply that PP and LN development are differentially
regulated and, in contrast to PP, that LN organogenesis
is only partially dependent on IL-7Ra.
It is generally accepted that the developmental program
for lympho-organogenesis is turned off after birth. How-
ever, in both reactive lymphoid hyperplasia and follicular
hyperplasia, remodeling of lymphoid tissue has been ob-
served. In addition, in inflammatory lesions of autoimmune
diseases, allergic reactions, microbial infections, and
chronic graft rejections, ectopic lymphoid tissues named
‘‘tertiary lymphoid organs’’ can develop (Aloisi and Pujol-
Borrell, 2006; Drayton et al., 2006).
Neonatal LN cell suspensions containing LTi cells and
stromal organizer cells injected intradermally into miceImmunity 26, 643–654, May 2007 ª2007 Elsevier Inc. 643
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Lympho-Organogenesis in IL-7 Transgenic MiceFigure 1. Monitoring of CIITA Tg and IL-7
Tg Expression in Fetal Mice
(A) Tg mice expressing CIITA ubiquitously
through MT50, MT30, and SRa elements were
crossed with MHC class II I-E IL-7 mice.
(B) The proportion of I-E+ cells in the E 14.5 FL
of WT and H-IL-7 mice was measured by flow
cytometry. Shown are cytogram displays of
cells stained with the indicated markers. Num-
bers in the quadrants indicate the percentage
of cells expressing the respective marker.
These data are representative for 5 indepen-
dent experiments.
(C and D) IL-7 transcripts were quantified by
real-time PCR in E14.5 fetal liver (C) and intes-
tine (D). Values were normalized to TATA box-
binding protein (TBP), and increase of IL-7
mRNA in H-IL-7 and IE-IL-7 compared to WT
controls are shown. Values represent the
mean of 3 to 5 mice.are able to aggregate and form lymphoid-like structures
(Cupedo et al., 2004). This study convincingly shows
that LTi cells are able to reorganize lymphoid stroma after
dissociation but it does not answer the question of
whether LTi cells are able to generate de novo ectopic
lymphoid organs.
In order to address this question, we have used IL-7
transgenic (Tg) mice expressing different amounts of IL-7.
In these mice, LTi cell numbers were increased as a result
of IL-7-dependent enhanced survival and, to a minor ex-
tent, proliferation of the cells. We observed multiple PP
developing throughout the entire small intestine, and in
addition, numerous organized ectopic LN (ELN) and cecal
lymphoid patches (LP) were formed. Ectopic lymphoid tis-
sue development was dependent on the presence of LTi
cells and their expression of LTa1b2. Our data demon-
strate that de novo lympho-organogenesis is a highly plas-
tic process, which can be regulated by IL-7, LTi cell num-
bers, and LTa1b2 expression. These data shed new light
on possible mechanisms involved in tertiary lymphoid
tissue development in chronic inflammatory diseases.
RESULTS
Fetal IL-7 Tg Expression Results in Increased
Number and Size of PP
To investigate the role of IL-7 in the formation of lymphoid
tissue, we used Tg mice expressing different amounts of
IL-7. In the first mouse type (IE-IL-7), murine IL-7 was ex-
pressed under the control of the MHC class II Ea promoter
(Mertsching et al., 1996). In the second type, IE-IL-7 mice
were crossed with animals expressing the MHC class II
transactivator (CIITA) under the control of the ubiquitous
SRa promoter (Figure 1A; Otten et al., 2003). The CIITA
transactivator increases transcription from MHC class II644 Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc.promoters, and therefore, in double Tg mice (H-IL-7
mice), the ubiquitous synthesis of CIITA promoted sys-
temic IL-7 Tg expression. In the E14.5 fetal liver (FL) of
wild-type (WT) (non-Tg litter control) mice, the majority
of cells were negative for MHC class II I-E and CD45
(Figure 1B). However, in H-IL-7 mice, 19.3% CD45+ and
19.9% CD45 cells expressed I-E as a consequence of
CIITA Tg expression in the FL. Accordingly, a 2.3- and
6.8-fold increase in total IL-7 transcripts was detectable
in the FL of IE-IL7 and of H-IL-7 mice, respectively, as
compared to WT controls (Figure 1C). In the fetal intestine,
IL-7 transcripts were increased only 2.3-fold in IE-IL-7 but
15.9-fold in the H-IL-7 mice (Figure 1D). At all ages tested,
IL-7 transcripts were more abundant in H-IL-7 Tg com-
pared with IE-IL-7 Tg mice (data not shown).
We used IE-IL-7 and H-IL-7 mice to test the effect of en-
hanced IL-7 availability on the formation of PP in the intes-
tine. Two VCAM-1+ PP anlagen were detectable in the
proximal small intestine of E16.5 WT and IE-IL-7 mice
(Figure 2A and data not shown). In E16.5 H-IL-7 mice,
a continuous band of VCAM-1+ cells could be identified
on the antimesenteric side of the entire small intestine
(Figure 2A). Coexpression of ICAM-1 and VCAM-1 is char-
acteristic of PP organizer cells (Adachi et al., 1997; Honda
et al., 2001). By flow cytometry, we found a 5-fold increase
in the percentage of VCAM-1+ ICAM-1+ organizer cells in
the small intestine of E16.5 fetal H-IL-7 mice (Figure 2B).
There was a clear correlation between high IL-7 expres-
sion and increased PP numbers with 6.6 ± 1.3 in WT and
8.0 ± 2.0 in IE-IL-7 but 31.4 ± 9.4 in H-IL-7 mice
(Figure 2C). The increase in PP numbers was found in
both the proximal and distal parts of the intestine
(Figure 2D). PP of H-IL-7 newborn animals were larger in
diameter, and in addition to isolated VCAM-1+ spots, elon-
gated clusters of VCAM-1+ cellular aggregates could be41
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Lympho-Organogenesis in IL-7 Transgenic MiceFigure 2. VCAM-1+ Organizer Cells Expand in the Developing Gut of H-IL-7 Mice
(A) Expression of VCAM-1 in the gut of E 16.5 WT and H-IL-7 mice detected by whole-mount immunohistochemistry. Dotted lines show VCAM-1+
cluster.
(B) The proportion of VCAM-1+ ICAM-1+ organizer cells in the E 16.5 gut was measured by flow cytometry. Number indicates the percentage of
VCAM-1+ ICAM-1+ cells.
(C) Total PP number in neonatal WT (n = 10), IE-IL-7 (n = 12), and H-IL-7 (n = 8) mice determined by VCAM-1 whole-mount immunohistochemistry.
Significantly different values are indicated: ***p < 0.001.
(D) PP localization in newborn intestine of WT and H-IL-7 mice, indicated by arrows.
(E) VCAM-1+ cluster formation in newborn H-IL-7 mice indicated by dotted lines.identified (Figure 2E). Equivalent structures were not de-
tectable in IE-IL-7 or in WT mice. The phenotype of single
CIITA Tg mice was identical to WT mice, demonstrating
that CIITA overexpression alone had no effect on PP or-
ganogenesis (data not shown). Altogether, these data
demonstrate that the whole length of the antimesenteric
side of the gut was potentially capable of forming PP.
The additional PP seen in H-IL-7 mice were still detectable
in adults (Figure S1A in the Supplemental Data available
online). The number of lymphoid follicles found in individ-
ual PP was markedly increased in both IE-IL-7 and H-IL-7
mice (Figure S1B).
IL-7 Induces the Development of ELN and Cecal LP
To enumerate the number of LN in mice differing in IL-7 ex-
pression, Chicago blue dye was injected into the footpads
of adult H-IL-7, IE-IL-7, WT, and Il7/ mice. In Il7/ mice,
the number of LN was largely reduced or absent relative to
WT mice (Figure S2). In H-IL-7 mice, the size of LN was en-
larged relative to WT mice (Figure 3A), and multiple ELN
were found in various regions such as the axilla, mediasti-
num, and within the abdominal cavity (Figure 3A, Table 1;
Figure S3). In IE-IL-7, some but not all ELN were found
(Table 1). As expected, WT mice were completely free of
42ELN development. ELN contained a normal ratio of
CD4+ to CD8+ T cells (Figure 3B). 10% to 12% of cells
found in the LN of H-IL-7 mice were CD93+ CD19+ B cell
precursors (Figure 3B) expressing c-Kit (CD117) but not
IgM (data not shown). This is in agreement with previous
studies demonstrating that in IE-IL-7 mice, the number
of IL-7-dependent late pro-B, pre-BI, and pre-BII cells in
peripheral lymphoid organs was dramatically increased
(Mertsching et al., 1996). The absolute T and B cell num-
bers of ELN from H-IL-7 and inguinal LN (ILN) from WT
mice were comparable (Figure 3C). In contrast, CD4+
T cell and CD19+ B cell numbers were 2-fold increased
in ILN of H-IL-7 mice as compared to WT controls.
Immunohistochemical examination of ILN and ELN from
adult H-IL-7 mice revealed that, like WT mice, there was
a normal segregation into B cell follicles and paracortical
T cell areas (Figure 3D). Intriguingly, in all H-IL-7 mice ex-
amined, multiple LPs were found in the proximal cecum
(Figure 3E, middle two images) and colon (data not
shown). In contrast to isolated lymphoid follicles or inflam-
matory infiltrates, these LPs were organized into B cell fol-
licles interspersed with T cell zones (Figure 3E, bottom).
LPs were clearly distinguishable from the well-described
solitary lymphoid patch in the distal cecum of WT mice.Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc. 645
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Lympho-Organogenesis in IL-7 Transgenic MiceFigure 3. IL-7 Is Involved in the Development of Ectopic LN
(A) 4 days after s.c. injection of Chicago blue dye, the ILN of WT (left) and H-IL-7 (right) mice became apparent. An ELN (indicated by arrow) is shown in
proximity to the ILN of H-IL-7 mice.
(B) LN single-cell suspensions of H-IL-7 and WT mice were analyzed by flow cytometry with the indicated monoclonal antibody. Data are represen-
tative of 5 experiments.
(C) Absolute cell numbers (3106) of T and B cells in WT LN (inguinal) and H-IL-7 LN (inguinal) and ELN are shown.646 Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc.
43
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Lympho-Organogenesis in IL-7 Transgenic MiceThese results demonstrate that increased IL-7 availability
resulted in the ectopic formation of organized LN and of
intestinal LPs.
In order to test the functional activity of ELNs, mice were
injected s.c. with the T cell-dependent antigen 4-hydroxy-
3-nitrophenylacetyl hapten conjugated to chicken g globin
(NP-CGG) precipitated in Alum. 9 and 14 days after immu-
nization, the numbers of low- and high-affinity Ab-produc-
ing cells were tested in draining and nondraining LNs. The
number of specific Ab-producing cells in draining popliteal
LNs and ELNs increased between day 9 and 14, whereas
at no time tested were we able to detect NP-specific Ab-
producing cells in nondraining LNs (data not shown). On
day 14, draining popliteal LNs from WT and H-IL-7 mice
generated comparable numbers of specific Ab-secreting
cells after immunization, whereas the number of both
NP-specific high (NP3)- and low (NP30)-affinity Ab-
producing cells in ELN was dramatically increased (Fig-
ure 3F). Draining ELN contained germinal centers with
PNA+ and GL-7+ IgD cells, indicating that normal T-B col-
laboration occurred in ELN of immunized H-IL-7 mice
(Figure 3G). In order to determine immune responses at
earlier time points, we injected mouse mammary tumor
virus (SW) s.c. and measured Syndecan 1+ class IIlo plas-
mablast and Vb6+ CD4+ T cell responses on day 6 after im-
munization (Ardavin et al., 1999). The draining ELN and
popliteal LN showed comparable responses (data not
shown). Importantly, upon immunization with adjuvant,
a procedure that induces a local inflammatory response,
additional ELN were formed in H-IL-7 but not in WT
mice. Whereas in most naive H-IL-7 mice, 1 ELN was
Table 1. Increased Availability of IL-7 Induces Ectopic
LN
Number of Positive Mice
Ectopic LNs WT IE-IL-7 H-IL-7
Inguinal 0/12 2/11 11/13
Axillary 0/12 3/11 13/13
Mediastinal 0/12 2/11 12/13
Abdominal 0/12 1/11 13/13
Intercostal 0/12 0/11 9/13
Pancreatic 0/12 0/11 7/13
Cecal patches 0/12 3/11 13/13
4 days after Chicago blue injection into adult mice, quantita-
tive assessment of the number of mice generating the indi-
cated ectopic LN and cecal lymphoid patches was performed
by stereomicroscopy. WT (n = 12) mice were compared with
IE-IL-7 (n = 11) and H-IL-7 (n = 13) mice.44found symmetrically at both sides of the inguinal region
after injection, after immunization we found 3 to 4 addi-
tional ELNs exclusively at the site of injection. The im-
munization-induced ELNs contained a striking frequency
of NP-specific B cells (data not shown). Independently of
any immunization, we also found numerous ectopic lym-
phoid follicles in autoimmune target organs such as the
pancreas and salivary gland (data not shown). Taken to-
gether, our data indicate that the increased availability of
IL-7 led to the spontaneous and immunization-induced
formation of tertiary lymphoid organs.
LTi Cells Are Required for De Novo PP and LN
Formation in H-IL-7 Mice
In neonatal mice, RORgt, a nuclear orphan receptor, is
preferentially expressed in LTi cells, and RORg-deficient
mice lack LTi cells (Eberl et al., 2004; Sun et al., 2000).
To explore whether LTi cells were required for the de
novo formation of additional PP and LN, we backcrossed
H-IL-7 mice to RORg-deficient mice. Whole-mount
VCAM-1 immunostaining of newborn intestine from
H-IL-7 RORg-deficient mice revealed that PP develop-
ment was completely blocked (Figure 4A, right). This
was consistent with the absence of LTi cells in the spleen
of neonatal H-IL-7 RORg-deficient mice (Figure 4B, right).
ELN were absent in H-IL-7 RORg-deficient mice (Fig-
ure 4C), suggesting that their development was depen-
dent on the presence of LTi cells.
LTa1b2 expressed by LTi cells is a crucial component in
secondary lymphoid organ development. In order to test
whether the effect of increased IL-7 availability was
LTa1b2 dependent, H-IL-7 mice were crossed to Lta
/
animals. As shown in Figure 4D, H-IL-7 Lta/ mice were
devoid of any ELN, thereby demonstrating that LTa1b2
was required for the formation of ectopic lymphoid tissue.
LTb transcripts were increased 3.8-fold in IE-IL-7 and
14.8-fold in the whole intestine of E16.5 H-IL-7 embryos,
respectively (Figure S4A) at a time when the majority of
LTa1b2-expressing cells in the gut are LTi cells. FACS anal-
ysis showed that the mean fluorescence intensity of
LTa1b2 on LTi cells was increased to the same extent in
both IE-IL-7 and H-IL-7 mice (Figures S4B and S4C). These
data suggest that the increase in total LTb transcripts in the
intestine of H-IL-7 mice was the result of both increased
LTa1b2 expression and frequency of LTi cells.
H-IL-7 Mice Have Elevated Numbers of LTi Cells
The elevated amount of LTb transcripts in fetal H-IL-7
mice prompted us to quantify LTi cell numbers in these
mice. A 4-fold and 23-fold increase in mean number of
LTi cells was observed in the spleen of E16.5 (1.8 3 103(D) Immunohistochemistry of frozen sections of LN of 4-week-old WT mice and H-IL-7 with anti-B220 (brown) and-CD3 (blue) Ab.
(E) Multiple cecal LPs were identified in H-IL-7 mice (indicated by arrows). Immunohistochemical staining of cecal LPs with the indicated Ab is shown
in the lower panel.
(F) Number of NP3 and NP30-specific Ab-secreting cells per 105 total LN (popliteal) cells from WT and LN (popliteal) and ELN cells from H-IL-7 mice 2
weeks after s.c. immunization with NP-CGG and alum (n = 3–5).
(G) Immunofluorescence staining of draining popliteal LN (WT) and ELN (H-IL-7) of mice 2 weeks after s.c. immunization with NP-CGG and alum. MAb
specific for IgD (red) and GL-7 (green) as well as PNA (green) were used. Data are representative for analysis of three individual mice per group.Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc. 647
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Lympho-Organogenesis in IL-7 Transgenic MiceFigure 4. RORg and LTi Cells Are Required for PP Amplification in H-IL-7 Mice
(A) Whole-mount immunohistochemistry (anti-VCAM-1) of intestine isolated from neonatal WT (RORg-heterozygous littermates), H-IL-7 (RORg het-
erozygous), and H-IL-7 RORgKO (RORg-deficient) mice. PP anlagen are indicated by arrows. A mean of 5 PP was found in WT (n = 7), 21 PP in H-IL-7
(n = 3), and 0 PP in H-IL-7 RORg KO mice (n = 3).
(B) Flow cytometry analysis of single-cell suspensions from neonatal spleen of WT, H-IL-7, and H-IL-7 RORgKO mice. The circular gates were used to
calculate the percentage of CD4+CD3 cells among total lymphocytes.
(C) The number of ELN found in individual mice is shown. 3 to 7 mice per group were analyzed.
(D) H-IL-7 mice were backcrossed to Lta/ mice and the number of ELN was determined. 3 to 4 mice per group were analyzed.cells) and neonatal (2.33 104 cells) H-IL-7 mice (n = 6) rel-
ative to WT controls (n = 6) (Figure 5A). Similarly, a signifi-
cant increase in mean LTi cell number was also observed
in LN of H-IL-7 mice (n = 6) (Figure 5B). LTi cell numbers
were not significantly elevated in fetal and neonatal
IE-IL-7 mice. Our results were further supplemented by
analysis of the gut of newborn (D 3.5) mice. We observed
a massive colonization of the H-IL-7 small intestine by LTi
cells (Figure 5C, top right). These LTi cells were not found
within clusters of CD3+ T cells (Figure 5C, top), but were
forming tight follicles before B220+ B cells accumulated
in these segregated areas (Figure 5C, bottom left). In con-
trast to CD4+ cells, VCAM-1+ organizer cells were not ex-
pressing IL-7Ra, making it unlikely that organizer cells
were directly responsive to IL-7 (Figure 5C, bottom middle
and right).
We have previously shown that adoptively transferred
LTi cells from WT mice are able to restore PP formation
in neonatal Cxcr5/ mice (Finke et al., 2002). In order to
test whether CD4+CD3 cells from H-IL-7 mice were func-
tional LTi cells, sorted CD4+CD3 cells were adoptively
transferred into neonatal Cxcr5/ mice. Transfer of
9000 sorted cells was sufficient to induce the develop-648 Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc.ment of 10 PP in Cxcr5/ mice, a number comparable
to that in WT mice (Figure S5A). The PP-like follicles in re-
constituted Cxcr5/ mice, however, were smaller as
compared to PP in WT mice, probably as a result of inef-
ficient colonization with CXCR5-deficient B cells. One of
the hallmarks of LTi cells is their expression of RORgt tran-
scripts. Therefore, to confirm that the CD4+CD3 cells
found in H-IL-7 mice were LTi cells, we determined the
amount of RORgt transcripts in sorted LTi cells from neo-
natal spleen of H-IL-7 mice (Figure S5B). As negative con-
trol, CD4+ T cells from H-IL-7 mice were used, and as pos-
itive control, total thymocytes from WT animals were used.
RORgt transcripts were found in CD4+CD3 cells and, as
expected, in thymocytes. Similarly, thymocytes from H-
IL-7 mice were positive for RORgt transcripts (data not
shown). Altogether these data show that CD4+CD3 cells
found in high numbers in H-IL-7 mice are functional LTi
cells.
IL-7 Is a Survival Factor for Fetal Progenitor
and LTi Cells
It was reported that IL-7Ra+ lin FL cells were progenitors
of LTi cells and that they expressed a4b7 integrin (Mebius45
Immunity
Lympho-Organogenesis in IL-7 Transgenic MiceFigure 5. IL-7-Dependent Increase in LTi Cell Numbers
(A) Flow cytometry of splenocytes from E16.5 fetal and newborn (n = 6) WT, IE-IL-7, and H-IL-7 mice. A live gate was used to exclude dead cells.
Shown are mean values ± SD. Significantly different values of absolute cell numbers are indicated: **p% 0.01, *p < 0.05. For newborn spleen (right)
a logarithmic scale was used.
(B) The absolute number of CD4+ CD3 LTi cells in mesenteric LN (n = 6) from WT, IE-IL-7, and H-IL-7 mice.
(C) Immunohistochemistry of serial frozen sections from small intestinal PP of WT, IE-IL-7, and H-IL-7 mice 3.5 days after birth stained with the
indicated Ab. The antimesenteric side of the intestine is highlighted by a dotted line. Data are representative for analysis of 3 to 4 mice per group.et al., 2001; Yoshida et al., 2001). To explore whether
these FL progenitors were already expanded in H-IL-7
mice, we examined the absolute number of a4b7+ FL cells
in the E14.5 FL. Comparing fetal WT with H-IL-7 mice
(E14.5), the absolute number of a4b7+ FL cells was in-
creased more than 2-fold (Figure 6A). We could clearly
discriminate these FL progenitors from early B cell-
committed precursors, which were B220hi and CD19hi.
To determine whether the increase in a4b7+ progenitors
was the result of IL-7-driven proliferation, we pulsed E14.5
pregnant mice with bromodeoxyuridine (BrdU) and after
1.5 hr labeling determined BrdU incorporation into a4b7+
progenitor cells by flow cytometry (Figure 6B). No differ-
ence in proportion of proliferating cells was observed
when WT mice (34.9% of gated cells, mean fluorescence
intensity [MFI] 36) were compared with H-IL-7 mice (31%
of gated cells, MFI 32.7). To determine the rate of prolifer-
ating LTi cells, a 5 hr in vivo BrdU pulse of newborn ani-
mals was performed. The proportion of labeled LTi cells
in the spleen of WT mice (13%, MFI 92) and H-IL-7 mice
(8%, MFI 70) were not significantly different.
In order to investigate whether IL-7 promoted the sur-
vival of LTi cells and their progenitors, sorted a4b7+ cells
isolated from FL of E14.5 WT mice were cocultured with
ST-2 stromal cells. In the absence of added IL-7, the
absolute number of a4b7+ cells at day 9 of culture dramat-
ically dropped, and cells completely disappeared in cul-
tures containing a blocking anti-IL-7Ra Ab (Figure 6C,
left). We were able to detect commitment of a4b7+ cells46into LTi cells provided IL-7 was present in culture (Fig-
ure 6C, right). In order to study the direct effect of IL-7 on
survival of LTi cells, sorted CD4+CD3 cells from newborn
spleen of H-IL-7 mice were cultured on stromal cells. In the
absence of added IL-7 and even more strikingly in cultures
containing anti-IL-7R Ab, LTi cell numbers were signifi-
cantly decreased (Figure 6D). Similar results were obtained
from studies with WT LTi cells (data not shown). To address
the question of whether cells became apoptotic in the ab-
sence of IL-7, a4b7+ FL cells from E14.5 WT mice were
sorted and cultured in the presence of IL-7. After 7 days,
IL-7 was withdrawn and 2 days later, Annexin V and
7AAD labeling of cells was performed. Our results show
that removal of IL-7 significantly increased the percent
Annexin V+ 7AAD+ apoptotic a4b7+ FL cells and their LTi
progeny (Figure 6E). These data were in agreement with
the observation that in fetal H-IL-7 mice, the expression
of FAS, a proapoptotic protein, was reduced (data not
shown). In order to confirm the effect of IL-7 on LTi cell
survival rather then proliferation, we tested carboxy fluo-
rescein succinimidyl ester (CFSE)-labeled hanging-drop
cultures of neonatal WT splenocytes. In the absence of
IL-7, cell recovery of LTi cells was reduced by 37% already
at day 1 of culture (Figure 6F, right). In contrast, the profiles
of CFSE fluorescence intensity at day 1 revealed no signif-
icant difference in the number of cell divisions with or with-
out IL-7 (Figure 6F, left). Flow cytometry of 3-day cultures
revealed that (1) all LTi cells had a reduced CFSE fluores-
cence intensity within 3 days indicating cell division andImmunity 26, 643–654, May 2007 ª2007 Elsevier Inc. 649
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(A) The absolute number of a4b7+ cells calculated with flow cytometry of E14.5 FL from WT (n = 4) and H-IL-7 mice (n = 6). Shown are mean
values ± SD.
(B) Flow cytometric analysis of BrdU incorporation into (left) a4b7+ cells derived from E14.5 FL (WT versus H-IL-7) and (right) splenic CD4+ CD3 LTi
cells derived from neonatal spleen (WT versus H-IL-7), after in vivo pulse with BrdU. The FACS profile is representative for 3 independent experiments
with 3 to 5 mice per group.
(C) 1.8 3 105 sorted a4b7+c-Kit+ lin FL cells from WT mice (E14.5, n = 8) were cultured on ST-2 stromal cells with or without IL-7 supernatant or
alternatively with blocking anti-IL-7Ra Ab. After 9 days, the absolute cell number of a4b7+c-Kit+ cells and CD4+CD3 LTi cells was determined.
The experiment was repeated three times. Data represent mean values ± SD. **p < 0.01.
(D) 5 3 103 sorted CD4+CD3 LTi cells of newborn H-IL-7 mice (n = 6) were cultured, and cell recovery was determined at day 15 of culture. Data
represent mean values ± SD.
(E) Sorted a4b7+c-Kit+ cells from FL of E14.5 WT mice (n = 8) were cultured for 7 days in medium containing IL-7 followed by incubation with or without
IL-7. 48 hr later, Annexin V labeling of 7AAD+ cells was determined in both a4b7+c-Kit+ and CD4+CD3 LTi cells. Data represent mean values ± SD.
(F) CFSE profiles of gated CD4+CD3 LTi cells among neonatal splenocytes from WT mice (n = 6) cultured for 1 and 3 days as hanging drops was
determined by flow cytometry (left). Dead cells were excluded from analysis by means of 7AAD. Right panel shows the mean percent recovery of
CD4+CD3 LTi cells after culture of splenocytes from six neonatal WT mice.(2) approximately half of the LTi cells cultured in the pres-
ence of IL-7 underwent one more division. We could not
fully exclude, however, that in the absence of IL-7, cycling
cells preferentially died. Altogether, our data indicate that
IL-7 was crucial for the survival of LTi cells and their fetal
liver progenitors.
DISCUSSION
In this study, we have shown that IL-7 was a growth factor
that directed survival of LTi cells. Increased in vivo avail-
ability of IL-7 in Tg mice led to the accumulation of LTi cells
and the formation of additional lymphoid organs. Mice650 Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc.overexpressing IL-7 but lacking either RORg, a factor
required for LTi cell generation, or LTa1b2 normally ex-
pressed by LTi cells, had neither PP nor ELN. Taken to-
gether, in this model, de novo organogenesis was clearly
dependent on IL-7, LTi cell number, and LTbR signaling.
During the past years, extensive studies have been per-
formed to better understand the pathogenic mechanism
for ectopic lymphoid tissue development, so-called ‘‘ter-
tiary lymphoid tissue’’ at sites of chronic inflammation. A
key role of IL-7 in immunopathology of persistent inflam-
mation has been discussed (Hartgring et al., 2006). Mice
carrying an IL-7 Tg fused to an immunoglobulin heavy
chain promoter/enhancer or an SRa-driven IL-7 Tg
47
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1993) and the colon (Watanabe et al., 1998), respectively.
In humans, ectopic lymphoid follicles are found in patients
with rheumatoid arthritis, and disease development posi-
tively correlates with high concentrations of serum and
synovial IL-7 (Takemura et al., 2001; van Roon et al.,
2005). Moreover, both IL-7 and its receptor are implicated
in multiple sclerosis pathogenesis (Booth et al., 2005;
Traggiai et al., 2001). A causal link between IL-7 produc-
tion and tertiary lymphoid tissue formation has not been
investigated so far.
Here we report that increased availability of IL-7 pro-
moted de novo formation of PP and LN through LTi cells,
because in H-IL-7 RORg-deficient mice, which lack LTi
cells, PP and ELN were completely absent and no induc-
tion of VCAM+ stromal cells was observed. Consistent
with this, transfer of LTi cells isolated from neonatal
H-IL-7 mice into newborn Cxcr5/ mice induced the for-
mation of PP-like structures, thereby confirming their
functional properties.
In normal mice, neonatal LN suspensions injected intra-
dermally can aggregate and form lymphoid-like structures
(Cupedo et al., 2004). This is in line with numerous studies
in mice demonstrating a striking capacity of lymphoid cell
suspensions, e.g., from fetal thymic lobes, to grow and re-
aggregate at ectopic sites (Anderson and Jenkinson,
2001). In Tg mice, the expression of TNF family member
molecules and chemokines driven by a pancreas-specific
promoter is followed by the development of intrapancre-
atic tertiary lymphoid tissue (for review see Drayton
et al., 2006). In these studies, the intriguing question re-
mained: are LTi cells responsible for the spontaneous for-
mation of lymphoid tissue at these ectopic sites? Our data
clearly demonstrated that in a mouse model with in-
creased IL-7 availability, multiple LN developed spontane-
ously at ectopic sites in an LTi cell-dependent manner,
and furthermore, these ELN had a normal architecture,
were connected to afferent and efferent lymphatics, and
were functional in that they participated in T cell-depen-
dent B cell responses. In addition, we showed that upon
immunization with adjuvant, a procedure that induces an
inflammatory response, multiple ELN harboring Ab-
producing cells were generated at sites of injection. This
indicated that in H-IL-7 mice, functional tertiary lymphoid
follicles were formed at sites of inflammation. Consistent
with the formation of tertiary lymphoid tissues in patients
with autoimmune diseases, naive H-IL-7 mice spontane-
ously developed tertiary lymphoid follicles in target organs
for autoimmune reactions such as pancreas and salivary
gland.
Compared to H-IL-7 mice, IE-IL-7 mice formed similar
numbers of follicles per PP but no additional PP, and fewer
ELN and cecal LP. These results suggested that either the
amount of IL-7 required for the formation of ELN and in-
crease in lymphoid follicle numbers was below the amount
required for the organogenesis of additional PP, or alter-
natively that the sites or onset of IL-7 expression in
IE-IL-7 mice differed from H-IL-7 mice, thereby not allow-
ing de novo formation of PP during embryonic develop-48ment. In addition, it is possible that the increased number
of follicles seen in IE-IL-7 and H-IL-7 mice was due to the
IL-7-driven increase in B and T cells, rather than an effect
during organogenesis. In agreement with this, local IL-7
Tg expression in enterocytes of Il7/ mice on a (B6x129
Ola)F1 hybrid background harboring some residual PP in
the jejunum and ileum could partially restore intestinal
lymphocyte compartments and PP numbers in the distal
small intestine but was unable to fully restore PP number
or size to that found in WT mice (Laky et al., 2000).
In a recent paper, the CCL21-driven formation of lym-
phoid structures in the thyroid gland was reported to oc-
cur independently of LTi cells but required the entry of
mature T cells (Marinkovic et al., 2006). It is likely that,
depending on the model and stimuli, other cell subsets
can contribute to the formation of ectopic tertiary lym-
phoid tissues. Various cell subsets, such as B cells, T
cells, and NK cells, can express substantial amounts of
LTa1b2 and, hence, may have a pivotal role in ectopic lym-
phoid tissue formation. In agreement with this, the contri-
bution of T and NK cells to postnatal LN development has
been reported (Coles et al., 2006). It remains to be eluci-
dated which additional signals, e.g., proinflammatory cy-
tokines or chemokines, are required for an LTi-indepen-
dent mechanism of tertiary lymphoid-tissue formation.
In fetal WT mice, IL-7 is produced by intestinal VCAM-1+
organizer cells (Nishikawa et al., 2003). We observed
a striking capacity of the entire small intestine of fetal
H-IL-7 mice to generate a continuous band of VCAM-1+ or-
ganizer cells on the antimesenteric wall before birth. The
fact that large numbers of LTi cells clustered to form aggre-
gates may explain the coalescence of VCAM-1 stainings in
neonates. Alternatively, there was an active mechanism
that allowed migration of VCAM-1 organizer cells into the
aggregates. This clearly demonstrates that VCAM-1+ PP
anlagen induction in the embryo was not fixed to particular
anatomical sites. A molecular feedback loop between IL-
7-producing VCAM-1+ PP organizer cells and IL-7-respon-
sive LTi cells might further contribute to cluster formation
and lympho-organogenesis. Indeed, IL-7 can induce
LTa1b2 expression by LTi cells, which is mandatory for
the engagement of LTbR on the organizer cells, and for
further lymphoid stroma differentiation (Honda et al.,
2001; Yoshida et al., 2002). Consistently, we observed
that LTa1b2 expression was upregulated on LTi cells of
both IE-IL-7 and H-IL-7 mice. Nevertheless, only in H-IL-
7 mice was an increase in PP number (5-fold) observed,
suggesting that increased LTa1b2 expression alone was
not sufficient to generate additional PP. In Lta/ H-IL-7
mice, ectopic LN and PP were undetectable, indicating
again that the de novo formation of lymphoid tissue was
strictly dependent on LTa1b2-expressing cells.
A direct role for IL-7 in LTi cell survival had not yet been
investigated. Here, we demonstrated that IL-7 was crucial
for the survival and subsequent cell division of LTi cells
and its FL progenitors. By using mice with either high or
intermediate IL-7 Tg expression, we observed that cell
numbers were amplified only if a high amount of IL-7
was available.Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc. 651
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49In the FL of E14.5 mice, IL-7R+ cells have been identified
as progenitors for LTi cells (Mebius et al., 2001; Yoshida
et al., 2001). In H-IL-7 mice, we found a 2-fold increase
in IL-7R+ a4b7+ FL cell numbers and a 3-fold increase in
the amount of IL-7 transcripts. We did not observe a signif-
icant in vivo effect of increased IL-7 availability on the rate
of proliferating a4b7+ FL progenitors and LTi cells. In vitro,
the presence of IL-7 for 1 day did not change the rate cell
divisions but substantially improved LTi cell recovery. In
the absence of IL-7 for 3 days, a further increase in the
proportion of apoptotic cells was observed. IL-7 also
had an effect on the rate of proliferation of LTi cells in vitro
at day 3, because approximately 50 percent of the cells
cultured in medium supplemented with IL-7 underwent
one more cell cycle. We cannot exclude that dividing cells
preferentially died without IL-7, thus explaining the differ-
ence in numbers of cycling cells. Both survival and subse-
quent cell division explain the in vivo and in vitro amplifica-
tion of a4b7+ FL progenitors and LTi cells. Likewise,
differentiation of a4b7+ FL progenitors into CD4+ CD3
LTi cells was dependent on the presence of IL-7. It is likely
that IL-7 delivers antiapoptotic signals to LTi cells, thus
promoting their survival. In line with this, the expression
of antiapoptotic Bcl family members such as Bcl-2 and
Bcl-X has been recently reported in LTi cells of fetal spleen
after a 5 day in vitro culture period in the presence of IL-7
(Kim et al., 2006).
Our data clearly show that the process of lymphoid-
organ formation is highly plastic and can be influenced
by the increased expression of IL-7 leading to the expan-
sion of the pool of LTi cells through preventing apoptosis.
The degree of lymphoid-tissue formation was tightly de-
pendent on the amount of IL-7. Our findings extend the
previously defined role of IL-7 for PP development to
a more general function of IL-7 in inducing lympho-organ-
ogenesis. In addition, they suggest that organized tertiary
lymphoid organs can develop, provided that IL-7 and suf-
ficient numbers of LTab-expressing LTi cells are available.
EXPERIMENTAL PROCEDURES
Mice
CIITA IL-7 double-transgenic mice (H-IL-7) were generated by cross-
ing heterozygous CIITA Tg females (Otten et al., 2003) with heterozy-
gous IL-7 Tg (IE-IL-7) males (Mertsching et al., 1996). Lta/ mice
were originally generated by De Togni and colleagues (De Togni
et al., 1994). Cxcr5/ mice were originally generated by Foerster
and colleagues (Forster et al., 1996). RORg-deficient mice were kindly
provided by D. Littman (Sun et al., 2000). Il7/ mice (von Freeden-
Jeffrey et al., 1995) were at least 8 times backcrossed to C57BL/6
mice. For visualizing LN, 1% Chicago sky blue 6B (Sigma-Aldrich)
diluted in PBS was injected s.c., and mice were analyzed 30 min or
4 days later. Mice were housed under standard conditions in a patho-
gen-free mouse facility. The study received the approval of the
Cantonal Veterinary Office of the city of Basel, Switzerland.
Adoptive Cell Transfer and Immunization
Sorted CD4+CD3 cells were injected intravenously (i.v.) into newborn
Cxcr5/ mice as previously described (Finke et al., 2002). For in vivo
immunization, adult age-matched WT and H-IL-7 mice were immu-
nized with one single s.c. injection of 50 mg of the T-dependent
B cell antigen NP-CGG (Biosearch Technologies) Alum precipitate.652 Immunity 26, 643–654, May 2007 ª2007 Elsevier Inc.1 and 2 weeks later, mice were sacrificed, and draining as well as non-
draining LN were analyzed for specific T-dependent B cell responses.
ELISPOT Assay
96-well Nunc Maxisorp plates were coated with 50 ml of NP-conju-
gated bovine serum albumin (NP-NP3 BSA and NP33-BSA at a concen-
tration of 5 mg/ml [Biosearch Technology Inc. Novato, CA]). After block-
ing with PBS/1% BSA, plates were incubated with various dilutions of
LN cell suspensions, followed by washing and incubation with biotiny-
lated goat anti-mouse Ig (CALTAG) overnight. After incubation with
streptavidin alkaline phosphatase (Boehringer Mannheim) in PBS/
Tween, substrate solution (5-Bromo-4-chloro-3-indolyl-phosphate
(Sigma) dissolved in 1-Amino-2-Methyl-1-Propanol (Sigma) was
added and stopped 4 hr later.
Flow Cytometry Analysis and Cell Sorting
Single-cell suspensions from fetal intestine (E16.5) were obtained by
incubating the intestine in PBS containing 1 mg/ml dispase (GIBCO)
for 15–25 min at 37C. Single cells derived from spleen, LN, intestine,
or FL were incubated with the anti-mouse FcgRII MAb (clone 2.4G2)
before incubation with a mix of fluorochrome-conjugated Ab. Sample
acquisition was performed with a FACScalibur (Becton Dickinson).
Cells were sorted with a FACS Aria (Becton Dickinson).
Antibodies
MAb either biotinylated or conjugated to fluorochromes (FITC, PE, PE-
Cy5, PE-Cy7, APC) were directed against the following mouse Ag:
CD45 (30-F11, Biolegend), MHC II (M5.114.15.2, Biolegend), CD3
(145-2C11, eBioscience), CD4 (H129, Biolegend), CD8 (53-6.7, Biole-
gend), CD11c (N418, eBioscience), CD19 (6D5, Biolegend), B220
(RA36B2, Biolegend), CD93 (AA4.1, eBioscience), IgD (1.19), Peanut
Agglutinin (Vector Laboratories), GL-7 (Ly-77, PharMingen), VCAM-1
(429, eBioscience), LTbR Ig (kind gift from J. Browning, Biogen, Cam-
bridge, MA), a4b7 (DATK 32, BD Bioscience), c-Kit (CD117) (ACK2,
eBioscience), and IL-7Ra (A7R34, eBioscience). Lineage cocktail mix
contained MAb specific for CD3, CD8, CD11c, CD11b (M1/70, Biole-
gend), CD19, B220, Gr-1 (RB6-8C5, eBioscience), and NK1.1
(PK136, eBioscience).
Analysis of Cell Proliferation and Cell Death
250 mg and 1.8 mg of BrdU diluted in PBS was injected i.p. into new-
born and E14.5 pregnant adult mice, respectively. 5 or 1.5 hr later,
mice were sacrificed, splenocytes harvested from newborn mice, or al-
ternatively FL cells cell suspensions were derived from E14.5 embryos,
and surface staining with MAb was performed as described before.
Cells were fixed, permeabilized, and stained with FITC-conjugated
anti-BrdU Ab (BD Pharmingen) or isotype controls according the man-
ufacturer’s instruction (BD Pharmingen). In order to determine cell di-
visions of LTi cells, total splenocytes from neonatal C57BL/6 mice
were labeled with 0.2 mM CFSE (Invitrogen) for 10 min at 37C. After
washing in PBS 10% FCS, cell suspensions were plated in a final con-
centration of 5 3 105 cells/30 ml in Terasaki plates, and plates were
inverted to generate hanging-drop cultures. 1 or 3 days later, cells
were harvested and analyzed by flow cytometry.
In order to determine the rate of apoptosis in FL and LTi cells cul-
tured with or without IL-7, FACS-sorted a4b7+ c-Kit+ lin cells were
cultured on irradiated (2000 Rad) ST-2 stromal cells in IMDM/FCS sup-
plemented with 3% IL-7 supernatant. After 7 days, IL-7 was withdrawn
from half of the plate and replaced by medium without IL-7. 48 hr later,
cells were harvested and analyzed with the Annexin V and 7AAD label-
ing kit from BD Pharmingen according to the manufacturers’ proto-
cols. In brief, 106 cells were surface stained with various Ab and resus-
pended in Annexin V binding buffer, followed by adding Annexin V-Cy5
and 7AAD. After 15 min incubation of the cell suspension at room tem-
perature, cells were analyzed by FACS Calibur.
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FACS-sorted a4b7+c-Kit+ lin FL cells (E14.5) and neonatal CD4+ lin
LTi cells were cultured in IMDM/FCS supplemented with antibiotics
(penicillin/streptomycin, ciproxine, kanamycin), 0.5 mg insulin per
100 ml, 0.1% mercaptoethanol, and 1% of nonessential amino acids
on irradiated (2000 Rad) ST-2 stromal cells with or without IL-7 super-
natant (3%) or with blocking anti-IL-7Ra Ab (clone A7R34; 50 mg/ml).
RT-PCR and Quantitative Real-Time PCR Analysis
For RT-PCR of RORgt, the following primers were used (forward [F], re-
verse [R]): RORgt [F] ACCTCCACTGCCAGCTGTGTGCTGTC, [R]
TCATTTCTGCACTTCTGCATGTAGACTG. The cycling conditions for
RORgt RT-PCR were: 5 min at 95C, followed by 35 cycles of 1 min
at 95C, 30 s at 65, and 45 s at 72C. The primers for the TATA box
binding protein (TBP) were used: [F] CCATTCTCAAACTCTGACCAC3,
[R] CCGTGGCTCTCTTATTCTCAT. The cycling condition for TBP RT-
PCR were: 5 min at 95C, followed by 35 cycles of 30 s at 95C, 30 s at
55C, and 30 s at 72C. Quantitative real-time PCR was performed
with the ROTOR-GENE RG-3000 with the sensiMix (dT) (Quantace).
The following primers were used: IL-7 [F] GATAGTAATTGCCCGAA
TAATGAACCA, [R] GTTTGTGTGCCTTGTGATACTGTTAG, LTb [F]
AATGCTTCCAGGAATCTAGCC, [R] CCAAGCGCCTATGAGGT, TBP
[F] CGTGAATCTTGGCTGTAAACT, [R] GTCCGTGGCTCTCTTATTCT.
The cycling conditions for IL-7 real-time PCR were: 10 min at 95C,
followed by 40 cycles of 10 s at 95C, 15 s at 60C, and 20 s at 72C.
The conditions for LTb real-time PCR were: 10 min at 94C, followed by
40 cycles of 10 s at 95C, 5 s at 60C, and 6 s at 72C. The relative ex-
pression of target genes was measured in triplicate and normalized to
the expression amount of TBP. The fold difference (as relative mRNA
Tg expression) between samples derived from H-IL-7, IE-IL-7, and
WT mice was calculated by the comparative CT method (DDCT) and
the received values were illustrated.
Immunohistochemistry and Immunofluorescence Microscopy
Immunostainings of frozen sections and whole-mount immuno-
histochemistry analysis of fetal (E16.5) and newborn intestine was per-
formed as previously described (Finke et al., 2002). For immuno-
fluorescence staining, 10 mm acetone-fixed cryosections of neonatal
intestine or adult LN were incubated with the primary rat anti-mouse
Ab, followed by incubation with the secondary goat anti-rat Ig Cy3
(Jackson ImmunoResearch) and by incubation with biotinylated rat
anti-mouse Ab in PBS. Sections were stained with Streptavidin Alexa
488 (Molecular Probes) in PBS/1% BSA and finally embedded in
Fluorsave (Calbiochem).
Statistical Analysis
To evaluate statistically significant differences, we used unpaired
two-tailed Student’s t test. p values less than 0.05 were considered
statistically significant.
Supplemental Data
Five figures are available at http://www.immunity.com/cgi/content/
full/26/5/643/DC1/.
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through Interleukin 7-Mediated Enhanced Survival  
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Figure S1. IL-7-Dependent Increase in PP Follicle Number 
(A) Microscopic inspection of adult PP following Chicago blue injection in WT, IE-IL-7 
and H-IL-7 mice. F, follicle number is indicated in the figure. (B) The percentage of 
individual PP with an average follicle number of 2-4, 5-7 of more than 8 is shown. Data 
were obtained from analyzing WT (n=8), IE-IL-7 (n=5) and H-IL-7 (n=5) mice. 
52
Immunity, Volume 26 
 
Figure S2. LN Development Is Impaired in Il7-/- Mice 
4 days after s.c. injection of Chicago blue dye, the number of indicated LN in adult Il7-/- mice 
(n=10) was assessed, and the percentage relative to WT numbers (100%) was calculated. 
 
Figure S3. Ectopic LN Development in H-IL-7 Mice 
In H-IL-7 mice with or without Chicago blue injection, ectopic LN (indicated by 
asterisk) are shown in the (A) axilla, (B) pancreas, (C) intercostal region and (D) 
randomly distributed in the deep subcutaneous region. ALN, axillary LN; BLN, brachial 
LN; ILN, inguinal LN; S, spleen.  
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Figure S4. IL-7 Promotes the Expression of LTα1β2 by LTi Cells In Vivo 
(A) LTβ-specific quantitative real time-PCR of total RNA isolated from the intestine 
of E16.5 fetal IE-IL-7 and H-IL-7 mice. The fold difference of LTβ mRNA comparing 
the indicated mice with WT controls is shown. (B) Gated on CD4+ CD3- LTi cells, 
LTβR-Fc staining of ex vivo isolated splenocytes and mesenteric LN of newborn IE-
IL-7 (bold) versus WT mice (thin), and (C) H-IL-7 (bold) versus WT mice (thin) is 
shown. LTi cells were negative for the lineage marker B220, CD19, CD11c, CD11b 
and NK1.1. Mean fluorescence values for LTα1β2 were: 60 and 178 for IE-IL-7 spleen 
and LN, and 107 and 137 for age-mached H-IL-7 mice spleen and LN versus 21 and 
109 for spleen and LNs in WT mice, respectively. Data are representative for 3 
experiments. As negative controls, splenocytes derived from Ltα-/- mice were used 
(shaded). 
 
Figure S5. CD4+CD3- Cells from H-IL-7 Mice Are Functional LTi Cells 
(A) 3 weeks after i.v. adoptive transfer of 500 or 9000 sorted CD4+CD3- cells from 
spleen of fetal H-IL-7 mice into neonatal Cxcr5-/- mice, VCAM-1 immunohistochemical 
analysis of recipient intestine was performed. As controls, untreated WT mice and 
Cxcr5-/- mice are shown. (B) RT-PCR of RNA isolated from FACS-sorted CD4+ CD3- 
LTi cells, and CD4+ CD3+ T cells derived from neonatal H-IL-7 mice and from total 
thymus of litter controls. The linear range of the RORγt –specific RT-PCR is shown by 
serial 2-fold dilutions of RNA. TATA box binding protein (TBP) was used as house-
keeping gene in the RT-PCR. For CD4+ CD3- LTi cells, RNA isolated from 1,800 cells 
(lane 1) to 112 cells (lane 5), for CD4+ CD3+ cells, RNA from 900 (lane 6) to 56 cells 
(lane 10) and for the thymus, RNA from 450 cells (lane 11) to 28 cells (lane 15) was 
used. C shows the H2O control. 
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 Abstract 
During fetal life, CD4+CD3- lymphoid tissue inducer (LTi) cells are required for lymph 
node and Peyer’s patch development in mice. In adult animals, CD4+CD3- cells are found in 
low numbers in lymphoid organs. Whether adult CD4+CD3- cells are LTi cells and are 
generated and maintained through cytokine signals has not been directly addressed. Here, we 
show that adult CD4+CD3- cells adoptively transferred into neonatal CXCR5-/- mice induced 
the formation of Peyer’s patches demonstrating for the first time their bona fide LTi function. 
Increasing IL-7 availability in wild type mice either by IL-7 transgene expression or treatment 
with IL-7/anti-IL-7 complexes increased adult LTi cell numbers through de novo generation 
from bone marrow cells and increased survival and proliferation of LTi cells. Our 
observations demonstrate that adult CD4+lin- cells are LTi cells and that the availability of IL-
7 determines the size of the adult LTi cell pool, which can trigger lymphoneogenesis. 
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 Introduction 
During fetal life, the development of secondary lymphoid organs in mice is determined by 
the interactions between lymphotoxin (LT)α1β2+CD45+CD4+CD3- LTi cells and 
mesenchymal LTβR+VCAM-1+ organizer cells (1, 2). The first lymph node (LN) and Peyer’s 
patch (PP) anlagen in fetal mice develop between embryonic day E13.5 and E15.5 from 
clusters of LTi and organizer cells (3, 4). The generation of LTi cells is dependent on the helix 
loop helix protein Id2 and the retinoic acid related orphan receptor RORγ (5, 6). In the 
absence of LTi cells or if the LTβR signalling pathway is perturbed, LNs and PPs do not form 
(7, 8). Moreover, IL-7 has an important role in LN and PP development (9) and we have 
recently shown that this relies on the IL-7-dependent survival of foetal LTi cells and their 
fetal liver (FL) progenitors (10). The number and localization of secondary lymphoid organs 
is developmentally fixed in mice. By increasing the pool of fetal LTi cells in vivo through IL-
7 transgene expression this restriction can be overcome leading to the formation of additional 
ectopic lymphoid organs. 
 Among CD3- cells, RORγt is an exclusive marker of fetal LTi cells (11). Fate mapping 
experiments with ROR(γt) +/GFP mice led to the conclusion that LTi cells persist in the gut of 
adult mice (12). In wild type (WT) adult mice, CD4+CD3- cells were found in the spleen 
where they help organize the architecture and optimize immune responses (13, 14). In 
addition, CD4+CD3- cells accumulate in the spleen of LCMV-infected mice (15). Neonatal 
and adult splenic CD4+CD3- cells display similar genetic profiles distinguishing them from 
other cells. Both express LTα, TNFα, c-Kit (CD117), IL-7Rα (CD127) and TNF receptors 
(TNFRII, TRANCER, HVEM) (16) but in contrast to adult cells, fetal LTi cells express 
neither CD30L nor OX40L (17) unless treated in vitro with IL-7 (17) or TNFSF15 (16), 
respectively. The mechanism for the generation and persistence of adult CD4+CD3- cells and 
their possible function as inducers of newly formed lymphoid organ remains to be addressed. 
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 In the present study, we firstly sought to determine whether adult CD4+CD3- cells have bona 
fide LTi activity and secondly, whether they could be expanded by increased availability of 
IL-7 either in transgenic or IL-7/anti-IL-7 complex-treated mice (18). Herein, we show that 
adult CD4+CD3- cells are functional LTi cells, which are dependent on RORγt and IL-7. 
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 Materials and Methods 
 
Mice and in vivo treatment 
H-IL-7, RORγ-/-, CXCR5-/- and IL-7-/- mice were previously described (10, 19). H-2k bcl-2 
transgenic mice were originally generated in the laboratory of I.L. Weissman (20) and kindly 
provided by A. Trumpp. Immune complexes containing 10 μg recombinant human IL-7 
(R&D) and 50 μg anti-IL-7 neutralizing monoclonal antibody (mAb) (M25) were i.p. injected 
into mice at day 0, 2 and 4, and mice were analyzed at day 7. If indicated, IL-7/anti-IL-7 
complex treatment was prolonged over 3 wks. FACS-sorted LTi cells were i.v. injected into 
neonatal CXCR5-/- mice as described (19). Splenocytes, LTi, BM or FL (E13.5) cells were i.v. 
injected into sublethally (600 Rad) irradiated mice (RAG-/-γc-/-, IL-7Rα-/- mice). Mice were 
housed under standard conditions in a pathogen-free mouse facility. The study received the 
approval of the Cantonal Veterinary Office of the city of Basel, Switzerland. 
 
Antibodies 
Abs either biotinylated or conjugated to fluorochromes (FITC, PE, PECy5, PeCy7 or APC) , 
purchased from BioLegend, eBioscience or BD Pharmingen, were used against the following 
mouse antigens: CD4 (clone: RM4-5), c-Kit/CD117 (2B8), CD3 (145-2C11), CD8 (53-6.7), 
TCRαβ (H57-597), TCRγδ (UC7-13D5), CD11c (N418), CD19 (6D5), B220 (RA3-6B2), 
NK1.1 (PK136), Gr-1 (RB6-8C5), TER119 (TER119), IL-7Rα (A7R34), CD18 (M18/2), β1 
integrin (HMb1-1), α4β7 integrin (DATK32), Sca-1 (D7), CD44 (IM7), CD62L (MEL-14), 
LTβR-huFc (gift from J. Browning), TRANCE (IK22/5), TRANCER (R12-31), ICAM-1 
(3E2), CD184 (2B11/CXCR4), CD45.1 (A20), CD45.2 (104), VCAM-1 (429), IL-7 (Lot 
number AWR01, R&D), M25 (mouse anti-human, Amgen). Secondary Abs were streptavidin 
(purchased from BioLegend) conjugated to FITC, PE, PECy5, PECy7 or APC, HRP-
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 conjugated goat anti-rat IgG (Biosource), Alexa Fluor 488 donkey anti-goat IgG (Invitrogen), 
Cy3-conjugated goat anti-rat IgG (Jackson ImmunoResearch).  
 
Flow cytometry and cell sorting  
106 cells derived from various lymphoid organs were stained with mAbs using standard 
protocols (10). Cells were resuspended in PBS containing 3% FCS, stained with biotinylated 
or fluorochrome-conjugated Abs and analyzed using a FACScalibur (Beckton Dickinson & 
Co). To analyse for the presence of LTi cells, total splenocytes from 6-8 wk old mice were 
depleted of erythrocytes, stained with biotinylated anti-CD4 Ab and enriched using MACS 
separation (Miltenyi Biotec). MACS-enriched cells were labelled with anti-CD4, anti-c-Kit 
and a cocktail of Abs specific for CD3, CD8, CD11c, CD19, B220, TCRαβ, TCRγδ, Gr-1, 
NK1.1 and TER119 (lin-cocktail). Data were analysed with the FlowJo software (Tree Star). 
A FACSaria (Becton Dickinson & Co) was used to sort adult LTi cells. 
 
Reverse Transcriptase (RT)-PCR 
RORγt- and TBP-specific RT-PCR were carried out as previously described (10). 
 
In vitro culture and proliferation assay in vitro and in vivo 
FACS-sorted LTi cells from H-IL-7 spleen were cultured on primary splenic stroma (15) in 
IMDM/FCS supplemented with antibiotics (penicillin/streptomycin, ciproxine, kanamycin), 
0.5 mg insulin per 100 ml, 0.1% β-mercaptoethanol, 1% non essential amino acids without or 
with blocking anti-IL-7Rα Ab (clone A7R34; 50 μg/ml). The presence and number of LTi 
cells was analyzed by flow cytometry after 8 days. 
To determine whether LTi cells proliferate in the presence of IL-7, sorted LTi cells from 
RAG-/- spleens were labelled with 1.25 μM CFSE (10 minutes at 37°C) and cultured on 
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 primary splenic stroma (15) with or without IL-7. After 7 days cells were analyzed by flow 
cytometry. To test in vivo proliferation, 108 CD4+ MACS-enriched CFSE-labelled splenocytes 
were adoptively transferred into irradiated mice.  
 
Immunofluorescence and immunohistochemistry 
Tissues were snap-frozen in Tissue-Tek O.C.T Compound (Sakura). 5-8 μm sections were 
fixed in acetone and rehydrated in PBS. For intracellular staining, slides were blocked in PBS 
0.2% gelatine (porcine skin, type A, Sigma) 1% donkey serum for 30 minutes and then 
incubated with primary Ab in PBS 0.2% gelatine overnight at 4°C. For surface staining, tissue 
sections were blocked in PBS 5% goat serum 1% BSA and then incubated with primary Ab 
for 1 hour at room temperature. Sections were washed and incubated with secondary Ab for 
45 minutes. For enzymatic immunohistochemistry, peroxidase activity was developed using 
3,3’-Diaminobenzidine tetrahydrochloride (Sigma). Slides were embedded in Moviol or 
Medimount (Medite). 
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 Results and Discussion 
Adult CD4+CD3- cells are LTi cells 
We investigated the LTi activity and number of CD4+CD3- cells in normal and IL-7 
overexpressing IL-7/CIITA double transgenic (referred to as H-IL-7) adult mice. The 
percentage of CD4+CD3- cells was increased 5-fold (Fig. 1A) and their number 30-fold in the 
spleens of H-IL-7 mice (Fig. 1B). In addition, adult CD4+CD3- numbers were increased in 
LNs (Fig.1C and D). IL-7 protein was present in VCAM-1+ CD45- cells in the splenic red 
pulp and was substantially increased in H-IL-7 mice (Supplementary Fig. S1A and B). 
Altogether, our findings demonstrate that increased IL-7 availability was associated with 
increased CD4+CD3- cell numbers in adult mice.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Adult CD4+lin- cells are found in adult mice. (A) Flow cytometry of total splenocytes from adult 
mice revealed that the percentage of CD4+lin- cells in H-IL-7 was 5 fold increased compared to WT (0.1% and 
0.02%, respectively). Lineage cocktail contained Abs against CD3, CD8, CD11c, CD19, B220 and NK1.1. (B) 
The absolute number of splenic CD4+lin- cells was 30 fold increased in H-IL-7 compared to WT (3.7x105 and 
1.1x104 cells, respectively). (n=12 mice per group, **p<0.05, Student t test) (C) CD4+lin- cells represented 
0.16% of total inguinal LN cells in H-IL-7 mice (n=6) compared to 0.04% cells in WT. (D) The absolute cell 
number of CD4+lin- cells was 19 fold increased in H-IL-7 as compared to WT LN. (n=5 mice per group, 
**p<0.05, Student t test)  
 
H-IL-7 mice were used as a source for isolating and characterizing adult CD4+CD3- cells. 
Adult CD4+CD3- cells expressed IL-7Rα, CD18, c-Kit, β1 integrin, α4β7 integrin, CD44 and 
63
 were negative for CD62L (Fig. S2A). Furthermore, they expressed LTαβ, tumor necrosis 
factor related activation-induced cytokine (TRANCE) and TRANCER (Fig. S2B). Transcripts 
for RORγt were found in adult CD4+CD3- cells (Fig. S2C). Hence, freshly-isolated fetal and 
adult cells share a common phenotype in vivo (Table I). Our data add new information to a 
previous study demonstrating that in vitro cultured fetal and adult CD4+CD3- cells display 
similar genetic fingerprints (16). In contrast to a previous report (17) we were unable to detect 
significant levels of OX40L and CD30L in adult CD4+CD3- cells (Table I). This discrepancy 
may rely on the fact that in our study we investigated freshly isolated cells whereas in other 
studies, adult CD4+CD3- cells were cultured overnight before testing.  
 
 
 
 
 
 
 
 
 
Table I. This table shows the surface expression profile of fetal and adult LTi cells in H-IL-7 mice. 
 
To investigate the function of adult CD4+CD3- cells, we adoptively transferred them into 
CXCR5-/- newborn mice. CXCR5-/- mice lack almost all PPs unless neonatally reconstituted 
with fetal LTi cells from WT origin (19). Hence, this assay was established to monitor the 
functional activity of LTi cells in the gut. Recipient mice were analyzed 3 weeks after 
adoptive transfer by anti-VCAM-1 immunohistochemistry of the whole intestine. Here, we 
show that PP numbers in CXCR5-/- mice were restored in direct proportion to the number of 
transferred adult CD4+CD3- cells (Fig. 2). 106 total splenocytes from WT animals were unable 
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 to restore PP formation in CXCR5-/- mice suggesting that among this number of cells, 
insufficient LTi cells were present. These data demonstrate for the first time that CD4+CD3- 
cells from adult mice are bona fide LTi cells. In a previous study it was shown that adult 
CD4+CD3- cells help reorganize the splenic architecture after LCMV infection (15). This 
effect appeared to be mediated by accelerated restoration of the splenic stromal cell 
compartment. In addition, a role of adult CD4+CD3- cells in creating organized T/B 
segregation in the adult spleen was proposed (14). Our study clearly shows that adult LTi 
cells can mediate the de novo generation of lymphoid tissue. In line with this, H-IL-7 mice 
developed not only ectopic LNs and additional PPs but also formed tertiary lymphoid organs 
in non-lymphoid organs such as salivary glands (unpublished observations). Altogether, adult 
CD4+CD3- cells have lymphoid tissue-inducing activity, which may contribute not only to 
lymphoid tissue organization but also to the neoformation of secondary and tertiary lymphoid 
organs. 
 
 
 
 
 
 
 
 
Figure 2. Adult CD4+lin- cells function as LTi cells. Various numbers of sorted LTi cells from H-IL-7 adult 
mice were i.v. transferred into CXCR5-/- newborn mice. As controls, 1x106 WT splenocytes were injected. 3 
weeks after transfer, the number of PPs was determined by anti-VCAM-1 immunohistochemistry of serial frozen 
sections (n=3 mice per group). 
 
Adult LTi cells are strictly dependent on IL-7 and RORγt 
In order to test if adult LTi cells and their precursors respond to IL-7, we treated WT and 
IL-7-/- mice with IL-7 or with a combination of IL-7 plus anti-IL-7 mAb M25. IL-7/anti-IL-7 
65
 complexes have been shown to display 50- to 100-fold higher biological activity than free IL-
7 (18). In line with this, within 7 days, the in vivo administration of IL-7/anti-IL-7 complexes 
significantly increased splenic LTi numbers in WT (Fig. 3A) and IL-7-/- (Fig. 3B) mice. IL-7 
treatment alone had no significant effect. Under steady state conditions, splenic CD4+CD3- 
cell numbers in WT and IL-7-/- mice were comparable. Because IL-7-/- mice have no 
peripheral LNs, LTi cells mainly accumulated in the spleen. Our in vivo data prompted us to 
speculate that IL-7 increased the number of adult LTi cells through supporting survival and/or 
proliferation. Indeed, survival of sorted splenic LTi cells cultured for 8 days was reduced by 
around 50% in the presence of neutralizing anti-IL-7R mAb (Fig. 3C). IL-7 had a slight effect 
on the proliferation of LTi cells in vitro (Fig. 3D) and after adoptive transfer into RAG-/-γc-/- 
mice in vivo (Fig. 3E). In RAG-/-γc-/- mice, adoptively transferred LTi cells proliferated 
vigorously even when no IL-7/anti-IL-7 complexes were injected. It is likely that in RAG-/-γc-
/- mice, elevated levels of IL-7 and/or additional factors supported their in vivo proliferation, 
which was increased after treatment with IL-7/anti-IL-7 complexes. Overexpression of either 
IL-7 or bcl-2 did not rescue LTi numbers in the spleen of adult RORγ-/- mice, thus 
demonstrating their strict dependence on RORγt (Fig. 3F). Additionally, we also 
demonstrated that the amount of IL-7 was able to regulate the pool of adult LTi cells. 
Fetal LTi cells have been reported to originate from multilineage FL precursor cells (21, 
22) whereas, postnatally, the BM is the major site of hematopoiesis. Although BM chimera 
experiments have given indirect evidence that the BM harbours cells, or precursors, which 
can help organizing the spleen, clear data about the generation of peripheral CD4+CD3- LTi 
cells from BM are still missing. In order to test if IL-7 can promote the generation of adult 
CD4+CD3- LTi cells from BM cells, we transplanted BM from adult WT (Ly5.1) mice into 
irradiated IL-7Rα-/- (Ly5.2) recipients and treated the mice with IL-7/anti-IL-7 complex or 
left them untreated. As controls we injected FL cells from E13.5 (Ly5.1) WT mice into 
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 irradiated IL-7Rα-/- (Ly5.2) recipients. As expected, in control mice receiving FL cells, a 
significant percentage of donor LTi cells (4.7 percent of lin- donor cells) was found in the 
spleen whereas donor LTi cells from WT BM were almost undetectable (0.8 percent of lin- 
donor cells) (Fig. 4). IL-7/anti-IL-7 complex treatment, however, significantly enhanced the 
generation of LTi cells (2.7 percent of lin- donor cells) from the BM. Mixed chimera 
experiments confirmed that FL cells were almost 10-fold more efficient at generating LTi 
cells as compared to BM cells (data not shown). This is likely a result of a stronger 
proliferation of fetal hematopoietic cells (23). As previously shown, administration of BrdU 
to pregnant mice labelled fetal LTi cells (10). Seven weeks after continuous treatment of 
pregnant mice (E12.5-E19.5) with BrdU, all LTi cells in the offspring had lost BrdU, whereas 
20% of maternal LTi cells were BrdU+ (data not shown). Therefore, LTi cells in fetal and 
adult mice differ in their proliferative status. 
Collectively, our data show that CD4+CD3- cells from adult mice are bona fide LTi cells 
and that increased availability of IL-7 enlarges the adult LTi cell pool through survival and 
proliferation of pre-existing LTi cells and the de novo generation of LTi cells. In vivo, LTi 
cells develop from BM precursors relatively inefficiently unless additional IL-7 is provided. 
Considering the role of LTi cells in normal and ectopic lymphoid tissue development (10), 
adult LTi cells may play an important role in chronic inflammatory diseases such as 
rheumatoid arthritis, where local IL-7 availability is increased (24). 
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 Figure 3. LTi cells are enriched in mice treated 
with IL-7/anti-IL-7 complexes. 6-8 wk old (A) WT 
or (B) IL-7-/- mice were either left untreated, treated 
with IL-7 or with IL-7/anti-IL-7 complexes. 7 days 
later, LTi cell numbers were significantly higher in 
treated than in untreated mice. Data are 
representative of 2 independent experiments with at 
least 5 mice per group. (C) LTi cells isolated from 
H-IL-7 spleen were cultured for 8 days without or 
with neutralizing anti-IL-7Rα Ab. (D) CFSE-
labelled LTi cells or pro-B cells from WT mice were 
cultured for 7 days with or without IL-7. (E) CD4-
enriched WT splenocytes were CFSE-labelled and 
injected into irradiated RAG-/-γc-/- mice. Mice were 
either left untreated or treated with IL-7/anti-IL-7 
complexes and analyzed 7 days later. (F) Flow 
cytometry of splenocytes from RORγ-/-, RORγ-/- x H-
IL-7 and RORγ-/- x bcl-2 transgenic mice. Cells were 
stained with a lin-cocktail, c-Kit and CD4. Gated on 
lin- cells, the percentage of CD4 and c-Kit-
expressing cells is shown. The density blots are 
representative for 3 mice per group. 
 
 
 
 
Figure 4. BM and FL can give rise to LTi cells in vivo. 1.5x106 
Ly5.1 BM cells or 5x105 Ly5.1 FL cells were injected into 
irradiated IL-7Rα-/- recipients either left untreated or treated with 
IL-7/anti-IL-7 complexes. 3 weeks later, splenocytes were 
analyzed by flow cytometry. Shown are representative data of 3 
mice after gating on lin- donor splenocytes. 
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 Supplementary Figures 
 
Supplementary Figure 1. IL-7 is expressed by VCAM-1+ cells in the splenic red pulp. Immunofluorescence 
of frozen spleen sections from 6-8 wk old (A) WT and (B) H-IL-7 mice using goat anti-mouse IL-7 Ab and rat 
anti-mouse VCAM-1 Ab. IL-7 was detected with an Alexa Fluor 488 donkey anti-goat IgG Ab (green) and 
VCAM-1 with a Cy3-conjugated goat anti-rat IgG Ab (red). F = Follicle. 
 
Supplementary Figure 2. Adult CD4+lin- cells share 
similar phenotype with fetal LTi cells. (A) Flow cytometry 
analysis of H-IL-7 adult spleen showed that CD4+lin- cells 
expressed IL-7Rα, CD18, β1 and α4β7 integrins, c-Kit and 
CD44. (B) Gated on CD4+lin- cells, all cells expressed 
LTαβ, TRANCE and TRANCER (bold line). Negative 
controls (filled) are LTα-/- splenocytes (left panel), CD19+ B 
cells (middle panel) and CD4+ T cells (right panel). (C) RT-
PCR of sorted CD4+lin- cells from spleen and thymocytes 
from adult H-IL-7 mice showed expression of RORγt. Serial 
dilutions of cDNA were performed and the house keeping 
gene TATA box binding protein (TBP) was used as internal 
control. 
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 Abstract 
The development of tertiary lymphoid organs (TLOs) often occurs at sites of chronic 
infection and inflammation. Until now, the mechanism for TLO development has not been 
solved. Here, we show that IL-7 overexpression in mice (H-IL-7 mice) leads to the formation 
of diffuse and organized TLOs in various non-lymphoid organs such as salivary gland and 
lung. The presence of naive follicular B, T and dendritic cells in TLOs correlates with the 
expression of the homeostatic chemokines CXCL13 and CCL21. Studies in LTα-/- and RORγ-
/- mice reveal that the organization of TLOs into B and T cell compartments, but not the 
generation of diffuse TLOs, may require the presence of LTβ-expressing LTi cells. 
Furthermore, the infection with Leishmania major triggers the de novo formation of ectopic 
lymph nodes (LNs) in H-IL-7 but not in WT mice, thus demonstrating a synergistic effect of 
inflammation and IL-7 in TLO development. Altogether, we firstly showed that IL-7 regulates 
the development of TLOs and secondly, that IL-7 and inflammation collaborate in de novo 
formation of ectopic LNs. 
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 Introduction 
During embryogenesis, the development of secondary lymphoid organs (SLOs), such as 
LNs and Peyer’s patches (PPs), results from interactions between CD45+CD4+CD3- lymphoid 
tissue inducer (LTi) cells and vascular cell adhesion molecule 1 (VCAM-1)+ mesenchymal 
organizer cells (1). In mice lacking LTi cells, such as RORγ- or Id2-deficient mice, the 
formation of LNs and PPs is absent (2, 3). LTi cells express lymphotoxin (LT) αβ (4), which 
is required for LN and PP development (5-7). The signalling via the lymphotoxin β receptor 
(LTβR) expressed by the organizer cells leads to the activation of the NFκB pathway and the 
consecutive production of the homeostatic chemokines CXCL13, CCL19 and CCL21 (8). 
These chemokines control lymphocyte recruitment and localization in segregated 
compartments of lymphoid organs (9). 
In human chronic inflammatory diseases such as Sjögren’s syndrome, Hashimoto 
thyroiditis, rheumatoid arthritis and multiple sclerosis the accumulation of lymphocytes in the 
inflamed organ often leads to the development of tertiary lymphoid organs (TLOs). In 
addition, chronic infection and chronic graft rejection trigger lymphoid neogenesis in non-
lymphoid organs (10, 11). The target organ undergoes complete remodelling with lymphoid 
stroma producing chemokines, thereby recruiting lymphocytes (12). The TLO 
microarchitecture contains some of the hallmarks of SLOs, such as B and T zone segregation, 
germinal centres (GCs) and high endothelial venules (HEVs). Mouse models with tissue-
specific overexpression of chemokines have shown that chemokines, by controlling the influx 
of lymphocytes, can induce the generation of TLOs (12, 13). For example, LTα expressed 
under the control of the rat insulin promoter (RIP) leads to the formation of inflammatory 
lesions in the pancreas and in the kidney (14), suggesting that LTα might play a pivotal role 
in TLO development (15). Tg mice with expression of CCL21 under the control of the 
thyroglobulin promoter develop ectopic organized lymphoid tissues in the thyroid gland. In 
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 this model, LT-expressing CD4+ T cells seem to be more important than B cells to initiate 
lymphangiogenesis (16). In some cases, lymphoid chemokines are expressed in inflamed 
tissues that do not have yet organized lymphoid tissue (17, 18), suggesting that these 
chemokines are induced by inflammation prior to the formation of segregated B and T cell 
areas. Early expression of homeostatic chemokines may be independent of LTαβ or TNF, as 
seen in influenza-infected lungs of LTα-/- mice (19). 
Whether LTi cells play a role in TLO formation is still unknown. More than ten years ago, 
an accumulation of CD4+CD3- cells has been observed in the spleen and liver of mice infected 
with helminth parasite (20). In a study using RIP-BLC tg mice, CD4+CD3- LTi cells were the 
first hematopoietic cells recruited to the islets (12), suggesting that LTi cells may be involved 
in TLO development. However, recent studies using mice expressing CCL21 in the thyroid 
gland show that the first cells appearing in the thyroid gland are CD4+ T cells and not LTi 
cells. Moreover, in CCL21 tg x Id2-/- mice, TLO formation was not affected (21), 
demonstrating that TLO development in the thyroid gland does not require LTi cells. 
Little is known about the role of Interleukin 7 (IL-7) and IL-7 receptor (IL-7R) α in TLO 
development and autoimmune diseases. In patients with rheumatoid arthritis, ectopic 
lymphoid follicle formation coincides with increased expression of IL-7 and IL-7Rα/IL-2Rγ 
(22), suggesting that IL-7 might be important for TLO formation. The IL-7R pathway might 
be involved in the development of multiple sclerosis (23, 24) as the progression of the disease 
positively correlates with concentrations of IL-7 in the serum and the synovial tissue (18, 25). 
In patients with Sjögren’s disease, the development of lymphocyte infiltrates in the salivary 
gland is associated with increased mRNA expression of IL-7 (26). Altogether, these results 
suggest that IL-7 may play a role in TLO development in organs affected by autoimmune 
diseases. We have previously shown the importance of IL-7 for LN and PP development. IL-
7-deficient mice lack some peripheral LNs and IL-7 overexpressing mice develop additional 
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 LNs and PPs (27). While data from clinical studies suggest a link between IL-7 availability 
and TLO formation, it is unclear whether increased availability of IL-7 is responsible for the 
formation of TLOs. 
Here we show that IL-7 overexpression leads to a massive generation of TLOs in the 
salivary gland, liver, pancreas, stomach and lung. The expression of homeostatic chemokines 
in the salivary gland, probably leading to the influx of T and B lymphocytes, might trigger 
TLO formation. Adult LTi cells and B cells are the major producers of LTαβ in these mice. 
Both populations are increased in numbers and are found in lymphoid infiltrates of the 
salivary gland, suggesting implication of both subsets in the formation of TLOs. Finally, we 
show that infection with Leishmania major leads to TLO formation and increase in LTi cell 
number. 
Altogether, these data show that the increased availability of IL-7 regulates the 
development of TLOs, and that upon infection, overexpression of IL-7 induces the de novo 
formation of lymphoid tissue, probably by increasing the pool of LTi cells. 
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 Results 
TLOs develop in non-lymphoid organs of IL-7 tg mice. To test if increased availability 
of IL-7 induced the development of TLOs, we analyzed non-lymphoid organs from mice 
expressing IL-7 transgene under the control of the Srα and I-E promoter (H-IL-7 mice (27)). 
In H-IL-7 but not in wild type (WT) or CIITA tg mice, we found several TLOs in the salivary 
gland (Fig. 1A, B and data not shown), the liver, pancreas, stomach, lung and brain 
(Supplementary fig. 1 and data not shown). TLOs were organized in segregated B and T cell 
regions (Fig. 1C) containing PNAd+ high endothelial venules (HEVs) (Fig 1D). TLOs were 
surrounded by LYVE-1+ lymphatic vessels (Fig. 1D) indicating that they were connected to 
the lymphatic vasculature. In addition, we found diffuse perivascular and periductal infiltrates 
composed of B, T cells and dendritic cells (DCs) (Fig. 1E, F). Of note, in these diffuse 
perivascular TLOs, CD4+CD3-CD11c- cells were detectable in close association with DCs 
(Fig. 1F and data not shown). We have previously reported that fetal and adult CD4+CD3- 
cells isolated from H-IL-7 mice are functional LTi cells ((28) and Schmutz, in revision). To 
better understand the relative contribution of LTi, B and T cells to TLO development, we 
analyzed the salivary glands of H-IL-7 mice 2 days, 2 and 4 weeks after birth. B cells entered 
the salivary gland of H-IL-7 mice around 2 weeks after birth (Fig. 1Gii), whereas LTi cells 
were already present by day 2 (Fig. 1Hi), their number increasing with time (Fig. 1Hii, Hiii). 
Organized lymphoid tissue with B and T cell zones did not develop before 4 weeks of age 
(Fig. 1Giii). These data strongly suggest that LTi cells colonized non-lymphoid organs before 
B and T cells and before segregation into B and T cell zones had occurred.  
 
Lymphocytes in TLOs of H-IL-7 mice are follicular-like B cells and naive T cells. To 
study if TLOs were composed of cellular subsets typically found in SLOs, we analyzed single 
cell suspensions from total salivary glands of H-IL-7 and WT control mice. Around 60% of 
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 the CD11c+ DCs isolated from the salivary gland of H-IL-7 mice were CD8α- CD11b+ DCs 
and around 5% were CD8α+CD11b- DCs (Fig. 2A). CD19+ B cells could be subdivided into 
B220high and B220low cells (Fig. 2B). B220high B cells were mainly follicular CD23+CD21+ B 
cells (Fig. 2C). B220low B cells were likely short lived plasmablast B cells which 
preferentially migrate to secretory glands (29). Accordingly, we identified few plasmablasts in 
both H-IL-7 and WT control mice (Fig. 2B and data not shown) ruling out a role of these cells 
in TLO development. Of note, immunofluorescence staining showed IgA+ B cells in H-IL-7 
salivary glands, as well as in WT salivary glands (Fig. 2H and data not shown). However, 
these IgA+ cells were different from B cells present in TLOs, which were negative for IgA 
(Fig. 2H). CD4+ and CD8+ T cells in the salivary gland of H-IL-7 mice expressed CD45RB 
and CD62L but were negative for CD25 and CD69 (Fig. 2D-G). This phenotype corresponds 
to naive T cells. Naive lymphocytes require CD62L to enter SLOs via HEVs. As shown 
before, HEVs were present in the TLOs of H-IL-7 salivary glands. Altogether our data 
indicate that SLOs and TLOs share the same subsets of hematopoietic cells, namely 
lymphocytes and DCs.  
 
Lymphoid chemokines and inflammatory cytokines are produced in TLOs. SLO 
stromal cells produce chemokines, which specifically recruit naive B and T cells thereby 
generating organized B and T cell zones (9). Our findings suggested that in H-IL-7 mice, 
incoming B and T cells responded to chemokines secreted by TLO stromal cells. To study 
this, we determined the expression of CCL19, CXCL13 and lymphoid stromal marker in the 
salivary glands of H-IL-7 mice. Both chemokines were expressed at places where TLO 
development was observed (Fig. 3A, B). Gp38+ stromal cells could be discriminated from 
LYVE-1+ lymphatic and CD31+ blood vessel endothelial cells (Fig.3C and data not shown). 
Altogether, these data suggest that ectopic chemokine expression in TLOs could contribute to 
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 the entry and localization of B and T cells. In addition to lymphoid chemokines we observed 
that several cytokines implicated during inflammatory responses were expressed at a higher 
level in H-IL-7 salivary glands compared to WT (Fig.3D). For example, IL-1α and IL-1β, 
which are pro-inflammatory cytokines, were more expressed in H-IL-7 salivary glands than in 
WT. IL-17, IL-23 and IL-27 are pro-inflammatory cytokines and were also induced in H-IL-7 
mice, as well as IL-16 and CCL5, which play a role in recruiting leukocytes to inflammatory 
sites. Surprisingly, IL-7 expression was low in H-IL-7 salivary gland. 
Altogether, these data show that H-IL-7 mice develop TLO and provide an environment 
that favours inflammatory reactions in non-lymphoid organs. 
 
Naive but not activated T cells home to TLOs. To test if naive or activated T cells 
migrate to TLOs in H-IL-7 mice, we adoptively transferred CFSE-labelled α-CD3-stimulated 
or freshly isolated T cells from OT-1 TCR tg mice. Mice were on a RAG-2-/- background to 
avoid any effect of endogenous TCR expression. 14 hours or 1 week after adoptive transfer, 
mice were sacrificed and sections of the spleen and salivary glands were analyzed by 
immunofluorescence for the presence of CFSE+ donor cells (Fig. 4 and data not shown). Only 
naive donor T cells migrated to the sites of TLOs in the salivary gland of H-IL-7 mice (Fig. 
4). Altogether, these data suggest that chemokines expressed in the salivary gland are able to 
recruit naive T cells. 
 
LTαβ signalling is required for the organization of TLOs 
To assess whether LTi cells determine the development of TLOs, we crossed H-IL-7 mice 
with RORγ-/- mice. The development of tertiary lymphoid tissue was not affected in these 
mice (data not shown). This means that formation of tertiary lymphoid tissue can still occur in 
absence of LTi cells. 
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 The activation of LTβR on stromal cells by LTαβ-expressing cells is required for SLO 
development (7). In order to test if LTβR–mediated signals were involved in the formation of 
TLOs, we crossed H-IL-7 mice on a LTα-/- background. As shown in Fig 5A, TLOs 
represented as diffuse infiltrates around the ducts, were detectable in the salivary gland of H-
IL-7 x LTα-/- mice. These data demonstrate that IL-7 overexpression may be sufficient to 
induce the recruitment of lymphocytes to non-lymphoid organs, but that the formation of 
organized TLOs was dependent on LTαβ-expressing cells. 
To identify the cells expressing LTαβ in the salivary gland of H-IL-7 mice, we analyzed 
single cell suspension from spleen of adult H-IL-7 mice. LTi cells and B cells clearly 
expressed LTαβ in H-IL-7 (Schmutz et al., in revision and Fig. 5B). Importantly, T cells from 
H-IL-7 mice were negative for LTαβ (Fig. 5B). Taken together, our findings suggest that both 
LTi cells and B cells could engage LTβR, which was crucial for the formation of organized 
TLOs. 
In order to know whether LTi cells required the presence of lymphocytes to colonize the 
salivary glands of H-IL-7 mice, we crossed H-IL-7 mice to RAG-/- mice. By 
immunofluorescence, LTi cells were detectable in H-IL-7 x RAG-/- salivary gland sections 
(Fig. 5C), showing that the presence of LTi cells in the salivary glands was independent of 
lymphocytes. 
 
TLOs develop at sites of Leishmania major infection in H-IL-7 mice. In humans, TLOs 
develop spontaneously at sites of chronic infection and inflammation (10). To test if IL-7 
could trigger the development of TLOs in inflamed tissue, we infected susceptible BALB/c, 
B6 litter controls and H-IL-7 (B6) mice into the footpad with Leishmania (L) major. The 
increase in footpad scale relative to non-infected controls (referred to as ILS (inflammatory 
lesion size)) was determined 6 weeks after injection. In WT mice, the ILS was between 0.3 to 
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 0.5 mm (data no shown) confirming previous data on the resistance of B6 mice against L. 
major (30). H-IL-7 mice, however, developed a significantly larger ILS as compared to WT 
controls (data not shown). Of note, LN-like TLOs developed next to the draining popliteal LN 
in H-IL-7 mice, but not in WT mice (Fig. 6A). Moreover, the size of the spleen increased with 
infection (Fig. 6A). Immunohistochemistry of TLOs revealed the formation of germinal 
centres (GCs), whereby size and number were comparable to GCs found in draining popliteal 
LNs of infected mice (Fig. 6B). The structure of the TLOs was comparable to draining WT 
and H-IL-7 LNs (Fig. 6C).  
In addition, there was a significant increase in the absolute number of LTi cells in the 
draining LNs of infected WT and H-IL-7 mice versus non-infected controls (Fig. 7A). In 
contrast, the number of LTi cells in the spleen of infected mice was similar to non-infected 
mice (data not shown). From these data we can conclude that the s.c. infection with L. major 
induces the de novo formation of functional TLOs provided increased amount of IL-7 is 
available. 
In the popliteal LN, the ratio between the percentages of CD4+ and CD8+ T cells were 
similar between non-infected and infected mice, regardless of the strain (Fig. 7B). But the 
total percentage of T cell decreased in WT mice as the percentage of CD19+ B cells increased 
(Fig. 7B). Moreover, the absolute numbers of CD4+, CD8+ and CD19+ cells increased in 
infected WT mice, as well as in infected H-IL-7 with only a minor increase in CD19+ B cell 
numbers (Fig. 7C). 
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 Discussion 
The formation of TLOs is a hallmark of autoimmune diseases and has been observed in 
several mouse models. Overexpression of various lymphoid homeostatic chemokines, such as 
CXCL13 and CCL21, has been studied. These data clearly show the potential of these 
chemokines to induce TLO formation in non-lymphoid organs. However, the role of 
cytokines, such as IL-7 remained unknown. Here we studied the effects of systemic 
expression of IL-7 in an IL-7 overexpressing mouse model. In H-IL-7 mice, the development 
of TLOs was observed in non-lymphoid organs. Ectopic lymphoid tissues found in non-
lymphoid organs were organized with B and T cell areas, probably segregated due to the 
expression of lymphoid chemokines. Moreover, TLOs formed in the salivary glands also 
contained LTi cells. Kinetic analysis of TLO development in the salivary gland of H-IL-7 
mice showed that LTi cells colonized the salivary gland before lymphocytes. This happens 
accordingly to the development of LNs during early life, where LTi cells are the first cells 
colonizing the anlage, followed by B cells and later on T cells (31). Large numbers of LTi 
cells may enter peripheral organs followed by the induction of CXCL12 on the endothelium, 
leading to influx of B and T cells. Another possible scenario is that lymphocytes infiltrate 
non-lymphoid organs randomly and hence induce chemokine expression on stroma and 
endothelium followed by further influx and organization. 
DCs were detected in TLO, where they might present self-antigens to T cells, thus 
triggering the development of ectopic lymphoid tissue, as proposed in a model of autoimmune 
diabetes (32). B cells found in the salivary gland of H-IL-7 mice had a follicular phenotype, 
although a population of plasmablast-like cells were found in H-IL-7 and WT salivary glands. 
B220low plasmablast-like cells found in the salivary gland of both H-IL-7 and WT mice were 
probably IgA-producing B cells, which are in steady-state conditions found in glands (29). 
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 T cells with a naive phenotype were found in the salivary gland. Interestingly, the transfer 
of either naive or activated T cells revealed that only naive T cells migrated to the salivary 
glands to places where TLOs were already present.  
Cell suspension of H-IL-7 salivary gland did not express IL-7, as shown by the cytokine 
array. However, by quantitative Real-Time PCR, we observed a significant increase in IL-7 
mRNA level in H-IL-7 salivary glands compared to WT salivary glands (data not shown), 
suggesting post-transcriptional modifications. By immunofluorescence, we showed the 
presence of CXCL13 in TLOs. On the cytokine array, CXCL13 was low in H-IL-7 salivary 
glands. This can be due to a diluting effect. CXCL12, however, was more expressed. This 
corresponds to data we obtained by immunofluorescence. Indeed, in H-IL-7 salivary glands, 
CXCL12 was ubiquitously expressed associated with endothelial cells. 
In H-IL-7 x RORγ-/- mice, lacking LTi cells, TLO development was not affected. This 
means that IL-7 is sufficient to induce the neoformation of lymphoid tissue. However, since 
H-IL-7 x LTα-/- mice only developed diffuse TLOs, LTαβ signalling seems to be critically 
required for TLO organization. This signal could be provided by LTi or B cells, which are the 
two populations expressing LTαβ in H-IL-7 spleen. In H-IL-7 mice, T cells do not express 
LTαβ, which is in contradiction with studies showing T and B cells expressing LTαβ and 
playing a role in TLO formation. However, alternative ligands for LTβR, such as LIGHT for 
example, may be important for TLO organogenesis (33, 34).  
TLO formation in H-IL-7 mice is similar to what happens in patients suffering from 
Sjögren syndrome (35). Sjögren syndrome is an autoimmune disease characterized by 
lymphocytic infiltrates in the salivary glands, followed by a decrease in the secretory 
response. Various mouse models have been used to study a particular aspect of Sjögren 
syndrome (reviewed in (36)). For example, in NOD mice, inflammatory reaction is observed, 
with B and T cell infiltrates in the salivary glands and a decrease in saliva flow (37). Human 
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 studies on Sjögren syndrome patients show that the organization level of the salivary gland 
infiltrates correlated with chemokine expression (38). 
In a model of parasite infection, we infected WT and H-IL-7 mice with L. major. Already 
two weeks after infection, H-IL-7 mice developed ectopic LNs in the region of the popliteal 
LN, which is the draining LN upon footpad infection with L. major. Moreover, the number of 
LTi cells significantly increased upon infection, in H-IL-7 mice, but also in WT mice. This 
increase could help regulating the infection. A recent study shows that during acute infection 
with Lymphocytic choriomeningitis virus (LCMV), the pool of LTi cells increases at the peak 
of infection, accelerating the restoration of the splenic architecture (39). 
Altogether, this study shows that the ectopic overexpresson of IL-7 is able to induce the de 
novo formation of lymphoid tissue at ectopic sites. Moreover, overexpressing IL-7 could be a 
useful tool to study the effect of increased availability of a cytokine in the development of 
autoimmune diseases. 
 
 
 
  
86
 Methods 
Mice 
H-IL-7 mice were obtained by breeding heterozygous CIITA tg mice (40) with heterozygous 
IL-7 tg mice (41). OT-I tg mice were kindly provided by J-Kirberg. RORγ-/- mice were kindly 
provided by D. Littman (2, 42). LTα-/- mice were originally generated by De Togni et al. (42). 
RAG-/- mice were kindly provided by G.Holländer and J. Kirberg.  
Antibodies 
Abs either biotinylated or conjugated to fluorochromes (FITC, PE, PECy5, PeCy7 or APC) , 
purchased from BioLegend, eBioscience or BD Pharmingen, were used against the following 
mouse antigens: CD4 (clone: RM4-5 or H129), c-Kit/CD117 (2B8), CD3 (145-2C11), CD8 
(53-6.7), TCRαβ (H57-597), TCRγδ (UC7-13D5), CD11c (N418), CD19 (6D5), B220 (RA3-
6B2), NK1.1 (PK136), Gr-1 (RB6-8C5), TER119 (TER119), CD21, CD23 (B3B4, 
Biolegend), CD44 (IM7), CD122(TM-b1), CD25 (PC61), CD45RB (16A), CD62L (MEL-
14), CD69 (H1.2F3), CD11b (M1/70), F4/80 (BM8), LTβR-Fc (gift from J. Browning), 
PNAd (MECA-79), Lyve-1 (polyclonal, RELIA Tech Gmbh), CD31 (*390), IgD (1.19), PNA 
(Vector Laboratories), CXCL13 (R&D), CCL19 (R&D), gp38 (R&D), VCAM-1 (429). 
Secondary Abs were streptavidin (purchased from BioLegend) conjugated to FITC, PE, 
PECy5, PECy7 or APC, Cy3-conjugated goat anti-rat IgG (Jackson ImmunoResearch), Alexa 
Fluor 488 donkey anti-goat IgG (Invitrogen), Alexa Fluor 488 goat anti-hamster IgG 
(Invitrogen), Alexa Fluor 488 goat anti-rabbit IgG (Molecular Probes) and streptavidin Alexa 
488 (Molecular Probes).  
Immunohistochemistry and Immunofluorescence 
For Haematoxylin Eosin staining, slides were stained in Haematoxylin (Medite) for 4 
minutes, rinsed in tap water, incubated 5 seconds in 70%EtOH 1%HCl, rinsed in tap water for 
10 minutes, stained in Eosin (Medite) for 10 seconds, briefly washed in tap water and finally 
dehydrated in EtOH 70%, 95% and 100%. Slides were incubated 5 minutes in xylenes 
(Sigma) before embedding in Pertex (Medite) for microscopical analysis. 
For Immunofluorescence staining tissue samples were snap frozen in O.C.T Compound. 5 μm 
sections were fixed in acetone, blocked and incubated with primary Abs for 1 hour. After 
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 washing, secondary Abs were added and incubated for 30 minutes. The slides were washed 
and mounted with Glycerol and 1,4-Diazabicyclo(2,2,2)octane (Sigma). 
Flow cytometry  
106 single cells derived from the spleen were resuspended in PBS containing 3% FCS and 
were stained with a mix of biotinylated or fluorochrome-conjugated Abs (see Ab section). 
Data were acquired using a FACScalibur (Beckton Dickinson & Co) and analysed with the 
FlowJo software (Tree Star). 
Isolation of cells from the salivary glands 
Salivary glands were isolated from anesthetized and PBS-perfused mice. They were cut in 
small pieces and incubated in 1 ml collagenase IV (10mg/ml, Sigma) for 1 hour at 37°C 
(agitating). Tissues were further homogenized with syringe and needle. The reaction was 
stopped by adding large volume of PBS 3% FCS. Cells were filtered before labelling with 
Abs for flow cytometry analysis. 
Mouse Cytokine Array Panel A Array Kit (R&D) 
This experiment was performed in agreement with the protocol given by R&D. 
Salivary gland cell suspensions were obtained by digestion of the salivary glands with 
collagenase (see previous section). 
Adoptive Cell Transfer 
For adoptive transfer of CFSE-labelled OT-I-derived T cells, splenocytes from OT-I Tg mice 
were depleted for erythrocytes. Splenocytes were labelled with CFSE (5-(and-6)-
carboxyfluorescein diacetate, succinimidyl ester, Molecular Probes) prior to i.v. injection into 
either H-IL-7 or WT recipients. Spleen and salivary gland of the recipient mice were analyzed 
after either 14h or 1 week by flow cytometry and immunofluorescence. 
Infection with Leishmania major 
Mice were infected s.c. in both footpads and the lesion sizes were followed until analysis. 
Mice were sacrificed for long term experiment after 7-8 weeks. 
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4. GENERAL DISCUSSION 
Using a mouse model where an IL-7 transgene is expressed systemically, we 
have previously shown that increased availability of IL-7 induces the development of 
ectopic LNs and additional PPs (1). Furthermore, we showed that increased IL-7 
regulated the number of LTi cells and induced higher expression of LTαβ by LTi cells. 
In H-IL-7 mice, the effect of IL-7 overexpression was already detectable in the E14.5 
embryo thereby increasing the number of LTi progenitors in the FL. We 
demonstrated that in vitro, IL-7 had a survival effect on α4β7+ FL progenitors and LTi 
cells. When we backcrossed H-IL-7 mice to RORγ-/- mice lacking LTi cells or LTα-/- 
mice, the development of PPs and ectopic LNs was blocked, speaking in favour of a 
LTi-dependent mechanism for ectopic follicle development. 
4.1. Characterization of adult LTi cells in H-IL-7 mice 
Fetal LTi cells express LTαβ, IL-7Rα, the chemokine receptors CXCR5 and CCR7, 
the adhesion molecules α4β1, α4β7 and ICAM-1. In this thesis work, I have 
characterized a population of CD4+lin- cells in the spleen, LNs and PPs of adult H-IL-
7 mice sharing the phenotype with fetal LTi cells, including the expression of RORγt. 
This is in agreement with previous studies describing LTi-like cells in the spleen of 
adult mice (21). In addition, LTi-like cells were found in the intestine of adult WT mice 
(35), where they were proposed to have a role in maintenance of mucosal immunity 
by organizing CPs and ILFs (35). Accordingly, RORγ+lin- cells in ILFs were shown to 
be responsible for inducing a T cell-independent Ig class switch towards IgA (37). 
This study further demonstrated that the signalling through Toll-like receptors (TLRs) 
was crucial for the RORγ+lin- cell-driven induction of IgA switching in vitro. However, 
the precise mechanism was unsolved, and it remains to be investigated if TLR 
ligands act on RORγ+lin- cells directly or alternatively, have an effect on the stroma 
compartments, which in turn support RORγ+lin- cells survival and function. 
Previous studies by Lane and colleagues have proposed that LTi-like cells play a 
role during splenic immune responses (98). LTi cells were described as accessory 
cells for priming T cells via the expression of CD30L and OX40L. In our mouse 
model, however, adult LTi cells express neither CD30L, nor OX40L. This discrepancy 
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might be explained by the fact that in the study of Lane and co-workers, the 
expression of these molecules was detected upon overnight culture, whereas I 
exclusively analysed freshly isolated cells. In my study, a 30 fold increase in CD4+lin- 
cell number was observed in H-IL-7 compared to WT mice suggesting that the 
increased availability of IL-7 had an effect on the generation and/or maintenance of 
CD4+lin- cells in adult mice. I could further show that adult CD4+lin- cells were able to 
induce lymphoid tissue formation upon transfer into CXCR5-/- mice lacking PPs, and 
were therefore bona fide LTi cells. As for transfer of neonatal LTi cells, PP-like 
follicles found in the small intestine of reconstituted CXCR5-/- mice were smaller than 
normal PPs in WT mice. In CXCR5-/- mice, B cells can colonize lymphoid tissue 
anlagen, but are unable to form mature follicles (99). This explains why PPs in 
CXCR5-/- mice reconstituted with LTi cells were smaller, and were lacking clearly 
segregated B cell follicles. It is likely that the co-transfer of WT BM would further 
improve the restoration of PP with mature B cell follicle formation in CXCR5-/- mice. 
The data presented here clearly show that the de novo formation of PPs in 
CXCR5-/- mice depends on the number of adult LTi cells transferred. Comparing the 
efficiency of fetal versus adult LTi cells to induce PP development in CXCR5-/- mice, 
we found that fetal cells were at least 3 times more efficient than adult LTi cells. 
Indeed, 5 x 104 adult LTi cells could induce the formation of 16 VCAM-1+ spots, 
whereas 2 x 104 fetal LTi cells were already sufficient to induce up to 33 VCAM-1+ 
spots (17). The reason for this lower efficiency of the adult LTi cells in not known. It is 
possible that the homing properties of the LTi cells differ between fetal and adult life 
due to various expression levels of chemokine receptors or adhesion molecules. 
Alternatively, the adult intestine is not as accessible as the fetal gut for adoptively 
transferred cells. It has been published that splenic adult LTi-like cells express the 
same level of LTβ, TNFα and LIGHT (40). However, the level of chemokine receptor 
expression has not been tested. Finally, it is possible that the survival rate and 
requirements for growth factors of LTi cells differ between fetal and adult life.  
Altogether, I have identified for the first time that LTi cells exist in SLOs of adult H-
IL-7 mice, which share the phenotype and function with fetal LTi cells. 
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4.2. Effect of IL-7 on WT LTi cells 
I could not exclude that due to the increased availability of IL-7, fetal LTi cells 
persisted throughout adult life. I therefore analyzed normal WT mice and RAG-/- mice 
for the presence of LTi cells. In WT spleen, a population of LTi cells was barely 
detectable, whereas in RAG-/- spleen, the number of LTi cells was significantly higher 
than in WT. One explanation is that due to the lack of IL-7-consuming mature T 
lymphocytes, the amount of total IL-7 protein was higher in RAG-/- mice, which lead to 
an increase in the absolute cell number of LTi cells.  
In order to test if a pool of LTi cells existed in adult WT mice that could respond to 
IL-7, I treated WT mice with recombinant IL-7 in combination with anti-IL-7 Ab. 
Complexes of IL-7 and anti-IL-7 Ab have been shown to possess 50 to 100-fold more 
biological activity than IL-7 alone (83). Indeed, when mice were treated with IL-7 
alone, no effect on the number of LTi cells was observed. However, mice treated with 
IL-7/anti-IL-7 Ab complexes displayed a significantly higher number of LTi cells. 
Interestingly, in IL-7-/- mice the number of LTi cells was also increased upon 
treatment with IL-7/anti-IL-7 Ab complexes, even more than in WT mice. IL-7-/- mice 
lack most of the peripheral LNs (1, 100). LTi cells might therefore accumulate in the 
spleen, whereas in WT mice, LTi cells are distributed amongst spleen, LNs and the 
MALT. This could explain why the effect of the treatment was more evident in the 
spleen of IL-7-/- than of WT mice. In addition, IL-7-/- mice have a severe defect in the 
generation of mature T cells, which could compete with LTi cells for growth and 
survival factors such as IL-7. Altogether, these data clearly show that there is a pool 
of LTi cells in adult WT mice that is responsive to IL-7. Furthermore, the data suggest 
that the amount of IL-7 available in vivo regulates the size of the LTi cell pool in adult 
mice. 
From these data, I asked whether IL-7 was implicated in the survival or in the 
proliferation of adult LTi cells. In order to test this, I cultured sorted adult LTi cells 
from WT spleen during 8 days either in the presence of IL-7 or in the presence of IL-
7Rα blocking Ab. After culture with IL-7Rα blocking Ab, the number of LTi cells was 
significantly decreased (50% of WT number) suggesting that IL-7 was a survival 
factor for LTi cells. I tested the proliferation of LTi cells in vitro by labelling adult LTi 
cells with CFSE, and culturing them on stromal cells in the presence or absence of 
IL-7. Analysing the CFSE expression level of LTi cells 7 days later, I observed one to 
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two more divisions of the cells cultured in the presence of IL-7. To compare these 
data with the proliferation in vivo, I adoptively transferred CFSE-labelled LTi cells into 
RAG-/-γc-/- mice. Seven days later, I observed two or three more divisions in mice 
treated with IL-7/anti-IL-7 Ab complexes compared to untreated mice. Of note, a 
significant proliferation of LTi cells occurred already without treatment. In RAG-/-γc-/- 
mice, neither T nor B or NK cells are present, which could potentially compete with 
LTi cells for the consumption of IL-7. This might explain the higher rate of 
proliferation of adult LTi cells in RAG-/-γc-/- mice. Altogether, these data suggest that 
IL-7 has a survival and a proliferative effect on adult LTi cells.  
4.3. Origin of adult LTi cells 
Whether LTi cells found in adult mice are derived from FL or from other 
progenitors present in adult mice remained an open question. In adult mice, the BM 
harbours hematopoietic progenitor cells, which could give rise to adult LTi cells (36, 
37). For example, common lymphoid progenitors (CLPs) express CD4 and c-Kit but 
are negative for all other lineage markers (101). A CLP-like progenitor cell has been 
described in the FL to give rise to fetal LTi cells (23). To address this question, we 
adoptively transferred FL or adult BM cells into IL-7Rα-/- mice. From previous studies 
we knew already that CD4-expressing LTi cells were absent from the FL. It was 
possible, however, that in the BM there were already pre-existing CD4+ LTi cells. 
Since we intended to determine the frequency of LTi precursor cells in the adult BM, 
we depleted the BM for CD4- (and CD8-) expressing cells. The same number of FL 
cells was 10 times more efficient than BM to give rise to LTi cells. After treatment of 
mice with IL-7/anti-IL-7 Ab complexes, the number of LTi cells was significantly 
increased. These data demonstrate that firstly, the adult BM harbours precursors of 
adult LTi cells. Secondly, IL-7 supported the bona fide generation of LTi cells derived 
from the adult BM. Thirdly, FL cells were able to give rise to LTi cells in an adult 
environment. Finally, the BM was far less efficient than FL in generating LTi cells in 
adult mice.  
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4.4. Adult LTi cells and TLO development 
H-IL-7 mice display an increased availability of IL-7. By quantitative real-time PCR, 
we found significantly higher levels of IL-7 mRNA in the salivary gland of H-IL-7 mice 
compared to WT mice (data not shown). However, at the protein level, we were 
unable to detect IL-7 either in the blood (data not shown) or in cell suspension of the 
salivary gland. Histology of the spleen revealed an increased expression of IL-7 
protein by VCAM-1+CD45- cells of the red pulp of H-IL-7 compared to WT mice. 
A correlation between increased level of IL-7 and the presence of TLOs has been 
shown in mouse models for autoimmune diseases such as RA (88), colitis (89, 90), 
multiple sclerosis (91) and diabetes (92). In our mouse model, diffuse or organized 
TLOs developed in various non-lymphoid organs such as salivary gland and lung. 
Interestingly, LTi cells were detectable in these TLOs. In order to test if LTi cells were 
required for the development of TLOs, I crossed H-IL-7 mice with RORγ-/- mice. 
These mice did not develop ectopic LNs or PPs, but the number of TLOs found in the 
salivary gland was not affected. These data show that the development of TLOs 
occurred independently of LTi cells. This confirms previous data obtained from a 
mouse model where the ectopic expression of CCL21 in the thyroid gland induced 
the development of TLOs. In these mice, the deletion of the Id2 gene, which is 
required for LTi cell generation, did not affect TLO formation demonstrating that the 
development of TLOs was independent of LTi cells (65). To test if LTβR signalling 
pathway was important for TLO development, I crossed H-IL-7 mice with LTα-/- mice. 
In the salivary gland of H-IL-7 LTα-/- mice only diffuse infiltrates around the ducts of 
the salivary gland were detectable, but no organized TLOs, suggesting that the LTβR 
pathway was critical for TLO organization. Adult mice harbour a wide variety of 
circulating mature lymphocytes expressing LTαβ. Amongst splenocytes of adult H-IL-
7 mice LTαβ was expressed by B and LTi cells, but was undetectable on naive T 
cells and DCs. Hence, both B and LTi cells might be potential candidates for 
providing LT signals required for TLO organization. In order to formally test the effect 
of the B cells it would be interesting to cross H-IL-7 mice with B cell-deficient μMT-/- 
mice.  
There is clear evidence that the colonization of the salivary gland of H-IL-7 mice 
with LTi cells precedes the infiltration with B cells. Analysis of the salivary glands of 
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H-IL-7 mice crossed with RAG-/- mice indicated that the recruitment of LTi cells to the 
salivary gland occurred independently of mature lymphocytes. By 
immunofluorescence, ubiquitous expression of CXCL12 was observed in the salivary 
gland of H-IL-7 mice. Similarly, cytokine arrays done with cell suspension from the 
salivary gland revealed that CXCL12 expression was higher in H-IL-7 compared to 
WT mice. CXCL12 is expressed in many non-lymphoid organs closely associated 
with endothelial cells (102). Since LTi cells express the corresponding chemokine 
receptor CXCR4, CXCL12 may be responsible for the recruitment of the cells to the 
salivary glands. CXCL13+ and CCL21+ cells were also detected in the salivary gland 
of H-IL-7 mice, but in contrast to CXCL12, only in the stroma compartments of TLOs. 
It is therefore possible that a combination of chemokine-mediated signals navigates 
LTi cells to developing TLOs. The interaction of LTi cells with stromal cells via 
LTαβ/LTβR might further stimulate the production of CXCL13 and CCL21, but is not 
absolutely required for the establishment of TLOs in H-IL-7 mice.  
In H-IL-7 mice, some TLOs found in non-lymphoid organs were organized into B 
and T cell areas. B cells isolated from the salivary gland of H-IL-7 mice had a 
follicular-like phenotype. In IE-IL-7 tg mice, which express IL-7 under the control of 
the MHC II promoter, the IL-7-driven increase in B lymphopoiesis affected follicular 
but not marginal zone B cell numbers (103). This might explain why only follicular B 
cells were present in TLOs. In the salivary gland of both WT and H-IL-7 mice, some 
IgA+ plasma cells were detectable by flow cytometry. This is in agreement with the 
fact that in all mucosal tissues, IgA is the prominent Ig isotype produced by B cells. 
Immunohistochemistry, however, revealed that in TLOs of the salivary gland from H-
IL-7 mice, B cells were IgA-. This means that B cells present in TLOs differ from 
normal plasmablasts found in mucosal tissue. 
By transfer of naive or in vitro- activated T cells from OT-I tg x RAG-2-/- mice, I 
could show that only naive T cells migrated to TLOs in the salivary gland of H-IL-7 
mice. Naive T cells are known to express CD62L (L-Selectin), which enables them to 
transiently bind to PNAd+ HEV in LNs. The development of HEVs in LNs depends on 
LTβR signalling (104). In mice which lack HEVs due to blocking LTβR signalling, the 
number of naive T cells in LNs is largely reduced. TLOs in H-IL-7 mice clearly 
contained HEVs. It is therefore possible that LTαβ-expressing LTi cells and later B 
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cells promoted the development of HEVs in TLOs of the salivary gland, thereby 
facilitating the entry of naive T cells. 
In autoimmune diseases, TLOs can harbour GCs with auto-reactive CD4+ T and B 
cells. For example, in Sjögren’s syndrome, the formation of functional GCs is 
observed in the salivary gland, with the production of auto-Abs (70). In a study about 
rheumatoid synovitis, three independent factors were defined as critical for the 
formation of GCs in non-lymphoid organs: CXCL13, CCL21 and LTαβ (62). The 
differentiation of FDCs and influx of CD4+ T cells may also support the generation of 
ectopic GCs. In H-IL-7, CXCL13 and CCL21 were produced in the TLOs of the 
salivary gland, suggesting a remodelling of the salivary gland with differentiation of 
lymphoid stroma. B cells and LTi cells expressed LTαβ, and could therefore be 
responsible for the activation of LTβR+ stromal cells followed by the production of 
CXCL13 and CCL21. It remains to be investigated if in H-IL-7 mice, the engagement 
of LTβR on stromal cells of the salivary gland (e.g. fibroblast, myofibroblasts, 
pericytes) results in the transformation into lymphoid stroma or rather differentiation 
of a lymphoid stromal cell from precursor cells that yet need to be defined. 
Despite the production of homeostatic chemokines and LTαβ in the salivary gland 
of H-IL-7 mice, organized TLOs in these mice did not contain GCs. These data 
suggest that immune response to foreign Ags or auto-Ags did not occur in these 
mice. In agreement with this, neither auto-Abs, nor immune complexes were found in 
H-IL-7 salivary glands or in the serum (data not shown). One plausible explanation is 
that the frequency of auto-reactive T or B cells in H-IL-7 mice was too low to establish 
an immune response. Alternatively, auto-Ags in the salivary gland were not 
accessible to specific lymphocytes. In line with this, in thyroid autoimmune diseases, 
it was reported that components of the thyroid gland were presented as auto-Ags, 
and that cytotoxic CD8+ T cells specific for thyroid Ags were critical for triggering GC 
reactions in non-lymphoid organs, probably through cell lysis and release of auto-Ags 
(105). Altogether, our data together with previous studies lead to the concept that 
TLO development alone is not sufficient to trigger autoimmune diseases, and that the 
recognition of auto-Ag determines the outcome of the disease. It is tempting to 
speculate that inflammatory cytokines and local release of IL-7 may be the starting 
point for TLO formation. Whether TLOs are beneficial for clearing a chronic infection, 
or harmful in case of autoimmune diseases, are still open questions, which remain to 
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be investigated. For example, blocking the LT pathway might be helpful in order to 
prevent autoimmune reactions in non-lymphoid organs (106). 
 
The H-IL-7 mouse model can be a useful tool to study if TLOs help clearing 
infections or may promote the maintenance of chronic immune stimulation in models 
for autoimmune diseases such as collagen-induced arthritis. 
4.5. TLO development during infection 
Upon infection with influenza, the development of TLOs was observed in the lungs 
(63). In patients with chronic post-inflammatory lymph stasis, the neogenesis of local 
LNs has been reported (107). This would suggest that inflammatory and post-
inflammatory signals can trigger de novo TLO development. We have previously 
shown that the injection of NP-CGG/Alum into the footpad of H-IL-7 but not WT mice 
triggered the development of additional ectopic LNs draining the site of injection (1). I 
therefore asked if inflammatory signals and IL-7 could have synergistic effects on the 
formation of TLOs. In order to study this we tested the effect of Leishmania (L.) major 
infection on TLO development in H-IL-7 mice and litter controls. In H-IL-7 mice, 
additional LNs were never observed in the popliteal region. Therefore, L.major 
parasites were injected s.c. into the footpad of mice, and the presence or absence of 
additional popliteal LNs after infection was analyzed. Interestingly, in around four out 
of sixteen H-IL-7 infected mice, the presence of ectopic LN could be detected in the 
popliteal region. These data show that, provided IL-7 was overexpressed, the 
infection induced the de novo formation of additional LNs. In WT and H-IL-7 mice 
infected with L.major, the number of LTi cells was significantly increased compared to 
non-infected mice. These data show that adult LTi cells were specifically recruited to 
or amplified in newly formed lymphoid organs. These data are in agreement with our 
observations in TLO formation in the salivary of H-IL-7 mice, and shed new light on 
the role of inflammatory signals for the activation and function of LTi cells. 
4.6. Outlook 
Using an IL-7 tg mouse model I have shown that IL-7 is mandatory for regulating 
the size of the adult LTi cell pool. However, precise data about the locations where 
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adult LTi cells can persist in WT mice are still incomplete. Someone would predict 
that LTi cell niches are sites where IL-7 and other growth/survival factors are 
available. In adult mice, large amounts of IL-7 are detectable in the intestine and skin 
(Thomas Schueler, personal communication). It has indeed been recently shown that 
intestinal CPs of adult mice harbour RORγ+lin- cells (37) and can therefore be a 
reservoir for LTi cells in steady-state conditions. It remains to be investigated if LTi 
cells are found in the skin. I have shown that adult BM cells could differentiate into 
LTi cells in vivo. I was unable to detect LTi cells in the BM of WT or H-IL-7 mice, and 
therefore the BM may rather contain LTi cell precursors that could give rise to LTi 
cells if required. LTi cell precursors could also be stored in peripheral organs such as 
the spleen, the LNs or the gut. The mechanism of differentiation of LTi cell precursors 
into functional LTi cells either in the BM or peripheral lymphoid organs and intestine 
needs to be further determined.  
In addition to IL-7, other cytokines may be required for the maintenance of LTi 
cells during adulthood. For in vitro cultures of LTi cells, we used a combination of IL-
3, IL-6 and SCF. Besides IL-7, these cytokines contributed to the maintenance of the 
cells for a few weeks in culture. Whether other cytokines, such as FLT3L, would 
induce better cell growth and maintenance could be further investigated. FLT3 is 
expressed by many hematopoietic precursor cells. It is not known if LTi cells express 
this receptor, but adult LTi-like cells do not expand in response to FLT3L treatment in 
vivo (21). However, FLT3L-/-IL-7Rα-/- mice are completely devoid of LNs in contrast to 
IL-7Rα-/-, where still some LNs are detectable (108), suggesting a role of FLT3L on 
LTi cells or their precursors. 
The transcriptional control of differentiation of α4β7+ FL cells into LTi cells is not 
fully understood, but seems to require both Id2 and RORγt. Whether LTi-lineage-
specific transcription factors exist that are required for the generation of adult LTi 
cells remains an open question.  
Our data suggest that inflammatory signals stimulate either LTi precursor cell 
differentiation or proliferation or recruitment of mature LTi cells. Little is known about 
the homing of LTi cells and in case of inflammation and infection, the stimulation and 
recruitment of these cells need further investigation. Studies in mice where TLR are 
specifically deleted in LTi cells (cre/lox) would help to elucidate if TLR expression by 
LTi cells is essential for their function during infections. It is likely that in addition to 
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stromal cells, other cell subsets may interact with LTi cells during the process of SLO 
and TLO development. For example, the role of vascular endothelial cells and 
underlying pericytes could be object of future investigations. 
Finally, it will be important to study, if a cellular equivalent to fetal and adult LTi 
cells exist in humans. 
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